Donna Niedzwiecki | Scholars@Duke

Donna Niedzwiecki
Associate Professor of Biostatistics and Bioinformatics

Primary interests include clinical trials design and the design and analysis of biomarker and imaging studies especially in the areas of GI cancer, lymphoma, melanoma, transplant and cancer immunotherapy.

Current Appointments & Affiliations

Associate Professor of Biostatistics and Bioinformatics, Biostatistics & Bioinformatics, Basic Science Departments 2013
Member of the Duke Cancer Institute, Duke Cancer Institute, Institutes and Centers 1997

Contact Information

2424 Erwin Rd, Hock Plaza, Suite 802, Rm 8040, Durham, NC 27705
Duke Box 2717, Durham, NC 27710
niedz001@mc.duke.edu (919) 681-5030

Background
Education, Training, & Certifications
- Ph.D., Yale University 1984
Duke Appointment History
- Assistant Professor of Biostatistics and Bioinformatics, Biostatistics & Bioinformatics, Basic Science Departments 2007 - 2013
- Assistant Research Professor of Biostatistics and Bioinformatics, Biostatistics & Bioinformatics, Basic Science Departments 2000 - 2007
- Assistant Research Professor in Community and Family Medicine, Community and Family Medicine, Clinical Science Departments 1997 - 2000
- Instructor, Temporary in the Department of Community and Family Medicine, Community and Family Medicine, Clinical Science Departments 1997
Research
Selected Grants
- Alliance NCORP Research Base awarded by Mayo Clinic 2014 - 2019
- National Clinical Trials Network - Network Group Statistics and DMCs awarded by Mayo Clinic 2014 - 2017
- Impact of Celecoxib and Inflammation on Surival in Stage III Colon Cancer awarded by Dana Farber Cancer Institute 2016 - 2017
- Dietary & Lifestyle Determinants of Colon Cancer Recurrence & Survival awarded by Dana Farber Cancer Institute 2007 - 2017
- The Influence of Diet and Lifestyle on Patients with Advanced Colorectal Cancer awarded by Dana Farber Cancer Institute 2015 - 2016
- Mayo Alliance Foundation Funds awarded by Mayo Foundation 2012 - 2014
- Graft Engineering and Immunotherapy After Unrelated Cord Blood Transplantation awarded by National Institutes of Health 2007 - 2011
- Cancer and Leukemia Group B Statistical Center awarded by National Institutes of Health 1982 - 2010
- Targeting hCG-beta for Breast Cancer Immunotherapy awarded by National Institutes of Health 2004 - 2009
- Vaccination with Regulatory T Cell Depletion awarded by National Institutes of Health 2006 - 2008
- Immunotherapy using peptide MHC tetramer isolated Tcells awarded by National Institutes of Health 2002 - 2007
- Planning a Duke Academic Public Private Partnership Program (AP4) Center awarded by National Cancer Institute 2004 - 2006
- Elimination of Regulatory T Cells awarded by National Institutes of Health 2003 - 2005
- Prospective comparison of colonic imaging tests awarded by National Institutes of Health 2000 - 2005
- Immunotherapy with Renal Tumor RNA Transfected Dendritic Cells awarded by National Institutes of Health 2001 - 2005
- Dexasome Based Immunotherapy of Lung Cancer awarded by National Institutes of Health 2001 - 2004
- Immunotherapy with TRICOM Modified Dendritic Cells awarded by National Institutes of Health 2001 - 2003
Publications & Artistic Works
Selected Publications
- Conference Papers
  - Grothey, A, Sobrero, A, Meyerhardt, JA, Yoshino, T, Paul, J, Taieb, J, Souglakos, I, Kerr, R, Labianca, R, Shields, AF, Bonnetain, F, Yamanaka, T, Boukovinas, I, Shi, Q, Meyers, JP, Niedzwiecki, D, Torri, V, Sargent, DJ, Andre, T, and Iveson, T. "Prospective pooled analysis of six phase III trials investigating duration of adjuvant (adjuv) oxaliplatin-based therapy (3 vs 6 months) for patients (pts) with stage III colon cancer (CC): Updated results of IDEA (International Duration Evaluation of Adjuvant chemotherapy)." September 2017. Link to Item
  - Clarke, JM, Blobe, GC, Strickler, JH, Uronis, HE, Zafar, Y, Morse, M, Dropkin, E, Howard, L, O'Neill, M, Rushing, CN, Niedzwiecki, D, Watson, H, Arrowood, C, and Hurwitz, H. "Phase Ib study of regorafenib (rego) and PF-03446962 (PF) in patients with refractory metastatic colorectal cancer (mCRC) (REGAL)." May 20, 2016. Full Text Link to Item
  - Nixon, AB, Sibley, A, Hatch, AJ, Liu, Y, Jiang, C, Mulkey, F, Starr, MD, Brady, JC, Niedzwiecki, D, Innocenti, F, Venook, AP, Hochster, HS, Lenz, H-J, O'Neil, BH, Owzar, K, and Hurwitz, H. "Blood-based biomarkers in patients (pts) with metastatic colorectal cancer (mCRC) treated with FOLFOX or FOLFIRI plus bevacizumab (Bev), cetuximab (Cetux), or Bev plus Cetux: Results from CALGB 80405 (Alliance)." May 20, 2016. Full Text Link to Item
  - Strickler, JH, Rushing, CN, Uronis, HE, Morse, M, Blobe, GC, Zafar, Y, Hsu, SD, Arrowood, C, Ley, SH, Dropkin, E, Niedzwiecki, D, and Hurwitz, H. "Phase Ib study of cabozantinib plus panitumumab in KRAS wild-type (WT) metastatic colorectal cancer (mCRC)." May 20, 2016. Full Text Link to Item
  - Strickler, JH, Rangwala, FA, Rushing, C, Niedzwiecki, D, Altomare, I, Uronis, HE, Hsu, SD, Zafar, Y, Morse, M, Chang, DZ, Wells, JL, Blackwell, KL, Marcom, PK, Webb, AR, Dropkin, E, Arrowood, C, and Hurwitz, H. "X-TRAP: Phase I/II study of capecitabine (X) plus ziv-aflibercept (TRAP) in metastatic colorectal cancer (mCRC)." February 2016. Full Text
  - Innocenti, F, Owzar, K, Chen, J, Sibley, A, Niedzwiecki, D, Bertagnolli, M, Friedman, P, Furukawa, Y, Kubo, M, Ratain, M, Blanke, C, Heinz-Josef, L, Venook, A, and McLeod, H. "2007 A genome-wide association study (GWAS) of overall survival (OS) in 609 metastatic colorectal cancer (mCRC) patients treated with chemotherapy and biologics in CALGB 80405." September 2015. Full Text
  - Heinemann, V, Niedzwiecki, D, Pearline, RV, Grothey, A, Hochster, HS, Goldberg, RM, Innocenti, F, Mayer, RJ, Schilsky, RL, Blanke, CD, Bertagnolli, MM, Venook, AP, Stinzing, S, and O'Neil, BH. "Outcomes for FOLFIRI plus bevacizumab (BEV) or cetuximab (CET) in patients previously treated with oxaliplatin-based adjuvant therapy: A combined analysis of data from FIRE-3 and CALGB 80405." May 20, 2015. Link to Item
  - Innocenti, F, Owzar, K, Jiang, C, Sibley, A, Niedzwiecki, D, Lenz, H-J, Bertagnolli, MM, Friedman, PN, Furukawa, Y, Kubo, M, Ratain, MJ, Blanke, CD, Venook, AP, and McLeod, HL. "A genome-wide association study (GWAS) of overall survival (OS) in 609 metastatic colorectal cancer (mCRC) patients treated with chemotherapy and biologics in CALGB 80405." May 20, 2015. Link to Item
  - Kulke, MH, Niedzwiecki, D, Foster, NR, Fruth, B, Kunz, PL, Kennecke, HF, Wolin, EM, and Venook, AP. "Randomized phase II study of everolimus (E) versus everolimus plus bevacizumab (E plus B) in patients (Pts) with locally advanced or metastatic pancreatic neuroendocrine tumors (pNET), CALGB 80701 (Alliance)." May 20, 2015. Link to Item
  - Ng, K, Venook, AP, Sato, K, Yuan, C, Hollis, BW, Niedzwiecki, D, Ye, C, Chang, I-W, O'Neil, BH, Innocenti, F, Lenz, H-J, Blanke, CD, Mayer, RJ, Fuchs, CS, and Meyerhardt, JA. "Vitamin D status and survival of metastatic colorectal cancer patients: Results from CALGB/SWOG 80405 (Alliance)." May 20, 2015. Link to Item
  - Schrag, D, Dueck, AC, Naughton, MJ, Niedzwiecki, D, Earle, C, Shaw, JE, Grothey, A, Hochster, HS, Blanke, CD, and Venook, AP. "Cost of chemotherapy for metastatic colorectal cancer with either bevacizumab or cetuximab: Economic analysis of CALGB/SWOG 80405." May 20, 2015. Link to Item
  - Ng, K, Venook, AP, Sato, K, Hollis, BW, Niedzwiecki, D, Ye, C, Chang, I-W, O'Neil, BH, Innocenti, F, Lenz, H-J, Blanke, CD, Mayer, RJ, Fuchs, CS, and Meyerhardt, JA. "Vitamin D status and survival of metastatic colorectal cancer patients: Results from CALGB/SWOG 80405 (Alliance)." January 20, 2015. Full Text
  - Hatch, AJ, Pang, H, Starr, MD, Brady, JC, Jia, J, Jiang, C, Sibley, A, Owzar, K, Niedzwiecki, D, Venook, AP, Cushman, SM, Hurwitz, H, and Nixon, AB. "Prognostic and predictive blood-based biomarkers of overall survival (OS) in patients (pts) with advanced colorectal cancer (CRC) treated with cetuximab (C): Results from CALGB 80203 (Alliance)." May 20, 2014. Link to Item
  - Venook, AP, Niedzwiecki, D, Lenz, H-J, Innocenti, F, Mahoney, MR, O'Neil, BH, Shaw, JE, Polite, BN, Hochster, HS, Atkins, JN, Goldberg, RM, Mayer, RJ, Schilsky, RL, Bertagnolli, MM, Blanke, CD, Alliance, CLGB, SWOG, , and ECOG, . "CALGB/SWOG 80405: Phase III trial of irinotecan/5-FU/leucovorin (FOLFIRI) or oxaliplatin/5-FU/leucovorin (mFOLFOX6) with bevacizumab (RV) or cetuximab (CET) for patients (pts) with KRAS wild-type (wt) untreated metastatic adenocarcinoma of the colon or rectum (MCRC)." May 20, 2014. Link to Item
  - Hatch, AJ, Pang, H, Starr, MD, Brady, JC, Jia, J, Niedzwiecki, D, Venook, AP, Cushman, SM, Hurwitz, H, and Nixon, AB. "Prognostic and predictive blood-based biomarkers of overall survival (OS) in patients (pts) with advanced colorectal cancer (CRC) treated with cetuximab (C): Results from CALGB 80203 (Alliance)." January 20, 2014. Full Text
  - Niedzwiecki, D, Frankel, W, Venook, AP, Ye, X, Friedman, PN, Goldberg, RM, Mayer, RJ, Colacchio, TA, Kennedy, RD, Davison, T, O'Brien, EJ, Mulligan, J, Johnston, PG, Harkin, DP, Schilsky, RL, Bertagnolli, MM, and Innocenti, F. "Association between ColDx assay result and recurrence-free interval in stage II colon cancer patients on CALGB (Alliance) 9581." January 20, 2014. Full Text
  - Hurwitz, H, Cushman, S, Jiang, C, Shterev, I, Mahoney, MR, Niedzwiecki, D, Mayer, RJ, Venook, AP, Owzar, K, Nixon, AB, and Oncology, ACT. "Tumor markers of efficacy and resistance to cetuximab (C) treatment in metastatic colorectal cancer (mCRC): Results from CALGB 80203 (Alliance)." May 20, 2013. Link to Item
  - Naughton, MJ, Schrag, D, Venook, AP, Niedzwiecki, D, Anderson, RT, Lenz, H-J, and Grubbs, SS. "Quality of life (QOL) and toxicity among patients in CALGB 80405." May 20, 2013. Link to Item
  - Van Loon, K, Owzar, K, Jiang, C, Kindler, HL, Mulcahy, MF, Niedzwiecki, D, O'Reilly, EM, Fuchs, CS, Innocenti, F, and Venook, AP. "25-hydroxyvitamin D levels and survival in patients with advanced pancreatic cancer (APC): Findings from CALGB 80303." May 20, 2013. Link to Item
  - Morse, M, Hobeika, A, Chaudhry, A, Amalfitano, A, Niedzwiecki, D, Clay, TM, Osada, T, Devi, G, Burnett, BK, Weinhold, K, Hsu, SD, Blobe, GC, Xu, Y, Nguyen, S, Dua, R, Balcaitis, S, Gabitzsch, E, Balint, J, Jones, F, and Lyerly, HK. "Effect of the vaccine Ad5 [E1-, E2b-]-CEA(6D) on CEA-directed CMI responses in patients with advanced CEA-expressing malignancies in a phase I/II clinical trial." May 20, 2012. Link to Item
  - Kanda, J, Rizzieri, DA, Long, GD, Gasparetto, C, Chute, JP, Sullivan, KM, Morris, A, McPherson, J, Livingston, JA, Broadwater, G, Niedzwiecki, D, Chao, NJ, and Horwitz, ME. "The Impact of Lymphocyte Subset Recovery At 3 Months on Progression-Free Survival After Myeloablative Allogeneic Stem Cell Transplantation." November 18, 2011. Link to Item
  - Mahmoud, N, Lopatin, M, Clark-Langone, K, Lee, M, Niedzwiecki, D, and Venook, A. "1411 POSTER Endpoints for Validation of Tumour Markers for Recurrence Risk -Recurrence-free Interval (RFI), Disease-free Survival (DFS), Overall Survival (OS), and Colon-cancer Specific Survival (CCSS) in CALGB 9581." September 2011. Full Text
  - Lyerly, HK, Hobeika, A, Niedzwiecki, D, Osada, T, Marshall, J, Garrett, CR, Chang, DZ, Aklilu, M, Crocenzi, TS, Cole, DJ, Dessureault, S, Hsu, SD, Bulusu, A, Clary, BM, Annechiarico, R, Devi, G, Chadaram, V, Clay, TM, and Morse, M. "A dendritic cell-based vaccine effects on T-cell responses compared with a viral vector vaccine when administered to patients following resection of colorectal metastases in a randomized phase II study." May 20, 2011. Full Text
  - Morse, M, Niedzwiecki, D, Marshall, J, Garrett, CR, Chang, DZ, Aklilu, M, Crocenzi, TS, Cole, DJ, Dessureault, S, Hobeika, A, Osada, T, Clary, BM, Hsu, SD, Devi, G, Bulusu, A, Annechiarico, R, Chadaram, V, Clay, TM, and Lyerly, HK. "Survival rates among patients vaccinated following resection of colorectal cancer metastases in a phase II randomized study compared with contemporary controls." May 20, 2011. Full Text
  - Anand, S, Thomas, S, Corbet, K, Gasparetto, C, Long, GD, Lopez, R, Morris, AK, Rizzieri, DA, Sullivan, KM, Sung, AD, Sarantopoulos, S, Chao, NJ, Horwitz, ME, Kanda, J, Rizzieri, DA, Gasparetto, C, Long, GD, Chute, JP, Sullivan, KM, Morris, A, Smith, CA, Hogge, DE, Nitta, J, Song, K, Niedzwiecki, D, Chao, NJ, and Horwitz, ME. "Adult Umbilical Cord Blood Transplantation Using Myeloablative Thiotepa, Total Body Irradiation, and Fludarabine ConditioningAdult Dual Umbilical Cord Blood Transplantation Using Myeloablative Total Body Irradiation (1350cGy) and Fludarabine Conditioning (PublishedPublished)." November 19, 2010. Link to Item
  - Chiou, L-W, Kanda, J, Szabolcs, P, Sempowski, GE, Hale, J, Niedzwiecki, D, Broadwater, G, Chao, NJ, and Horwitz, ME. "A Comprehensive Comparison Immune Recovery In Adult Patients Following Allogeneic Umbilical Cord Blood, Matched Sibling and Matched Unrelated Donor Stem Cell Transplantation." November 19, 2010. Link to Item
  - Castor, J, Wood, R, Niedzwiecki, D, Muir, A, Palmer, S, and Shimpi, R. "Lung Transplantation Alters Esophageal Motility and is Associated with Abnormal pH Testing." October 2010. Link to Item
  - Morse, M, Hobeika, A, Osada, T, Berglund, P, Negri, S, Niedzwiecki, D, Hubby, B, Burnett, BK, Clay, TM, and Lyerly, HK. "Effect of a novel recombinant alphaviral vector on tolerance to self-antigen in the setting of elevated regulatory T cells." May 20, 2010. Full Text
  - Bertagnolli, MM, Niedzwiecki, D, Hall, M, Jewell, SD, Mayer, RJ, Goldberg, RM, Colacchio, TA, Warren, RS, and Redston, M. "Presence of 18q loss of heterozygosity (LOH) and disease-free and overall survival in stage II colon cancer: CALGB Protocol 9581." May 20, 2009. Link to Item
  - Fuchs, C, Ogino, S, Meyerhardt, JA, Irahara, N, Niedzwiecki, D, Hollis, D, Saltz, LB, Mayer, RJ, and Bertagnolli, MM. "KRAS mutation, cancer recurrence, and patient survival in stage III colon cancer: Findings from CALGB 89803." May 20, 2009. Link to Item
  - Clay, TM, Hobeika, A, Osada, T, Serra, D, Niedzwiecki, D, Lyerly, HK, and Morse, MA. "Depletion of human regulatory T cells (Treg) and antigen-specific immune responses to cancer vaccines." May 20, 2008. Full Text Link to Item
  - Mohamed, A, Niedzwiecki, D, Baker, JH, Vinesett, R, Martin, PL, Driscoll, TA, Prasad, VK, Parikh, S, Kurtzberg, J, and Szabolcs, P. "THE USE, SAFETY, AND EFFICACY OF DACLIZUMAB FOR STEROID REFRACTORY GRAFT-VERSUS-HOST-DISEASE (GVHD) AFTER UNRELATED CORD BLOOD TRANSPLANTATION (UCBT)." February 2008. Full Text Link to Item
  - Posner, MC, Niedzwiecki, D, Venook, AP, Hollis, DR, Schilsky, RL, Goldberg, RM, and Mayer, RJ. "A phase II prospective, multi-institutional trial (CALGB 89903) of adjuvant active specific immunotherapy following curative resection of colorectal cancer(CRC) hepatic metastases." February 2007. Link to Item
  - Damon, LE, Johnson, J, Niedzwiecki, D, Cheson, BD, Hurd, DD, Bartlett, NL, Byrd, JC, Kelly, M, Linker, C, and Canellos, GP. "Immuno-chemotherapy (IC) and autologous stem cell transplant (ASCT) for untreated patients (pts) with mantle cell lymphoma (MCL): CALGB 59909." November 16, 2006. Link to Item
  - Szabolcs, P, Peterson, BL, Niedzwiecki, D, Chao, N, and Kurtzberg, J. "Multivariate analysis of patient and graft specific factors among 330 recipients of unrelated cord blood transplant (UCBT) to predict risk of death from opportunistic infections in the first 6 months after UCBT." November 16, 2006. Link to Item
  - Bertagnolli, MM, Compton, CC, Niedzwiecki, D, Warren, RS, Jewell, S, Bailey, GP, Mayer, RJ, Goldberg, R, Saltz, L, and Redston, M. "Microsatellite instability predicts improved response to adjuvant therapy with irinotecan, 5-fluorouracil and leucovorin in stage III colon cancer." June 20, 2006. Link to Item
  - Blum, KA, Johnson, JL, Niedzwiecki, D, Cannellos, GP, Cheson, BD, and Bartlett, NL. "A phase II study of bortezomib in relapsed Hodgkin lymphoma: Preliminary results of CALGB 50206." June 20, 2006. Link to Item
  - Gajewski, TF, Niedzwiecki, D, Johnson, J, Linette, G, Bucher, C, Blaskovich, M, Sebti, S, and Haluska, F. "Phase II study of the farnesyltransferase inhibitor R115777 in advanced melanoma: CALGB 500104." June 20, 2006. Link to Item
  - Tepper, JE, Krasna, M, Niedzwiecki, D, Hollis, D, Reed, C, Goldberg, R, Rich, T, Kiel, K, and Mayer, R. "Superiority of trimodality therapy to surgery alone in esophageal cancer: Results of CALGB 9781." June 20, 2006. Link to Item
  - Venook, A, Niedzwiecki, D, Hollis, D, Sutherland, S, Goldberg, R, Alberts, S, Benson, A, Wade, J, Schilsky, R, and Mayer, R. "Phase III study of irinotecan/5FU/LV (FOLFIRI) or oxaliplatin/5FU/LV (FOLFOX) +/- cetuximab for patients (pts) with untreated metastatic adenocarcinoma of the colon or rectum (MCRC): CALGB 80203 preliminary results." June 20, 2006. Link to Item
  - Rizzieri, D, Chute, J, Horwitz, M, Gasparetto, C, Sullivan, K, Long, G, Morris, A, Niedzwiecki, D, and Nelson, C. "Non-myeloablative allogeneic transplantation with alemtuzumab, fludarabine and cyclophosphamide using 3-6/6 HLA matched donors." February 2006. Full Text Link to Item
  - Rizzieri, DA, Koh, LP, Long, GD, Gasparetto, C, Gong, JZ, Lagoo, AS, Niedzwiecki, D, Sullivan, KM, Chute, J, Horwitz, M, Ashley, M, and Chao, NJ. "Outcome and immune reconstitution following T cell depleted nonmyeloablative allogeneic transplantation using matched donors." November 16, 2005. Link to Item
  - Rizzieri, DA, Koh, LP, Long, GD, Gasparetto, C, Sullivan, KM, Horwitz, M, Chute, J, Gong, JZ, Lagoo, AS, Niedzwiecki, D, Lu, CX, Marshall, D, Dowell, JM, and Chao, NJ. "Partially HLA matched, non-myeloablative allogeneic transplantation." November 16, 2005. Link to Item
  - Fuchs, C, Meyerhardt, JA, Heseltine, DL, Niedzwiecki, D, Hollis, D, Chan, AT, Saltz, LB, Schilsky, RL, and Mayer, RJ. "Influence of regular aspirin use on survival for patients with stage III colon cancer: Findings from Intergroup trial CALGB 89803." June 1, 2005. Link to Item
  - Meyerhardt, JA, Heseltine, D, Niedzwiecki, D, Hollis, D, Saltz, LB, Mayer, RJ, Schilsky, RL, and Fuchs, CS. "The impact of physical activity on patients with stage III colon cancer: Findings from Intergroup trial CALGB 89803." June 1, 2005. Link to Item
  - Wilson, WH, Porcu, P, Hurd, D, Martin, SE, Czuczman, M, Niedzwiecki, D, Saint Louis, JD, Johnson, JL, Cheson, B, Canellos, GP, and Zelenetz, AD. "Phase II study of dose-adjusted EPOCH-R in untreated de novo CD20+ diffuse large B-cell lymphoma (DLBCL)-CALGB 50103." June 1, 2005. Link to Item
  - Szabolcs, P, Park, KD, Niedzwiecki, D, Sanders, L, Lee, YA, Marti, L, Reese, MI, and Kurtzberg, J. "Dendritic cell and T-cell subsets correlate with the development and site of acute GVHD following unrelated cord blood transplantation in children: A multivariate analysis." February 2005. Full Text Link to Item
  - Mamon, HJ, Niedzwiecki, D, Hollis, DR, Tan, B, Smith, J, Blackstock, AW, Tepper, JE, Goldberg, RM, Mayer, RJ, and Fuchs, CS. "Preliminary analysis of cancer and leukemia group B (CALGB) 80003: A phase II trial of gemcitabine, 5-fluorouracil (5FU), and radiation therapy (RT) in locally advanced non-metastatic pancreatic adenocarcinoma." 2005. Full Text Link to Item
  - Czuczman, MS, Porcu, P, Johnson, J, Niedzwiecki, D, Canellos, GP, and Cheson, BD. "CALGB 59901: Results of a phase II study of 506U78 in CTCL and PTCL." November 16, 2004. Link to Item
  - Damon, L, Niedzwiecki, D, Johnson, J, Cheson, B, Hurd, D, Barlett, N, Kelly, M, Linker, C, and Canellos, G. "Intense immunochemotherapy (IC) and autologous stem, cell transplant (ASCT) for untreated patients (pts) with mantle cell lymphoma (MCL): CALGB 59909. A preliminary report." November 16, 2004. Link to Item
  - Koh, LP, Gockerman, JP, Moore, JO, DeCastro, C, Long, GD, Gasparetto, C, Niedzwiecki, D, Edwards, J, Prosnitz, L, Horwitz, M, Chute, J, Morris, A, Lassiter, M, Loftis, J, Davis, P, Chao, NJ, and Rizzieri, DA. "Dose dense, high intensity induction therapy followed by early high dose chemotherapy (HDT) and autologous hematopoietic stem cell transplantation (AHSCT) for mantle cell lymphoma (MCL)." November 16, 2004. Link to Item
  - Smith, SM, Johnson, JL, Niedzwiecki, D, Eder, JP, Canellos, GP, Cheson, BD, and Bartlett, NL. "Sequential topoisomerase I (topo I) and topoisomerase II (topo II) inhibitors in relapsed/refractory aggressive NHL: Results of CALGB 59906, a phase II study of doxorubicin and topotecan." November 16, 2004. Link to Item
  - Szabolcs, P, Park, KD, Marti, L, Lee, YA, Reese, M, Sanders, L, Niedzwiecki, D, and Kurtzberg, J. "Dendritic and T cell subsets correlate with the development and site of acute GVHD following unrelated cord blood transplantation. A multivariate analysis of host, graft, and day+50 immune profile." November 16, 2004. Link to Item
  - Bertagnolli, MM, Redston, M, Miedema, B, Dowell, J, Niedzwiecki, D, Mayer, R, Fleshman, J, Bem, J, and Compton, C. "Sentinel node staging of resectable colon cancer: Results of CALGB 80001." July 15, 2004. Link to Item
  - Colacchio, TA, Niedzwiecki, D, Compton, C, Warren, R, Benson, AIB, Goldberg, R, Kerr, D, Fields, A, Hollis, D, and Mayer, R. "Phase III trial of adjuvant immunotherapy with MOAb 17-1A following resection for stage II adenocarcinoma of the colon (CALGB 9581)." July 15, 2004. Link to Item
  - Kulke, MH, Niedzwiecki, D, Tempero, MA, Hollis, DR, and Mayer, RJ. "A randomized phase II study of gemcitabine/cisplatin, gemcitabine fixed dose rate infusion, gemcitabine/docetaxel, or gemcitabinefirinotecan in patients with metastatic pancreatic cancer (CALGB 89904)." July 15, 2004. Link to Item
  - Ryan, DP, Niedzwiecki, D, Hollis, D, Miedema, BE, Wadler, S, Tepper, JE, and Mayer, RJ. "A phase I/II study of preoperative oxaliplatin (0), 5-fluorouracil (5-FU), and external beam radiation therapy (XRT) in locally advanced rectal cancer: CALGB 89901." July 15, 2004. Link to Item
  - Saltz, LB, Niedzwiecki, D, Hollis, D, Goldberg, RM, Hantel, A, Thomas, JP, Fields, ALA, Carver, G, and Mayer, RJ. "Irinotecan plus fluorouracil/leucovorin (IFL) versus fluorouracil/leucovorin alone (FL) in stage III colon cancer (intergroup trial CALGB C89803)." July 15, 2004. Link to Item
  - Szaboles, P, Park, KD, Reese, M, Marti, L, Sanders, L, Niedzwiecki, D, Lee, Y, DeOliveira, D, and Kurtzberg, J. "Immune reconstitution and the risk of opportunistic infections after unrelated cord blood transplantation. A multivariate analysis." March 24, 2004. Link to Item
  - Szabolcs, P, Park, K, Marti, L, Reese, M, Lee, Y, Oliveira, D, Sanders, L, Niedzwiecki, D, and Kutzberg, J. "The impact of immune reconstitution in the early post grafting period on the development of opportunistic infections after unrelated cord blood transplantation. A multivariate analysis of host, graft, and day +50 immune profile." February 2004. Full Text
  - Rizzieri, DA, Akabani, G, Zalutsky, M, Coleman, RE, Toaso, B, Anderson, E, Lagoo, A, Clayton, S, Niedzwiecki, D, Moore, JO, Gockerman, JP, DeCastro, C, Chao, NJ, Gasparetto, C, and Bigner, DD. "Phase I trial with pharmocokinetics, dosimetry, toxicity and response of anti-stromal therapy using I-131 labeled chimeric anti-tenascin therapy for lymphoma." November 16, 2003. Link to Item
  - Rizzieri, DA, Koh, LP, Long, GD, Gasparetto, C, Vredenburgh, JJ, Buckley, PJ, Gong, G, Lagoo, A, Davis, P, Lassiter, M, Rooney, B, Niedzwiecki, D, Waters-Pick, B, Burleson, J, Thompson, M, Johns, A, Folz, RJ, Horwtiz, ME, Sullivan, K, Morris, A, and Chao, NJ. "Clinical outcome and immune reconstitution following alemtuzumab T cell depleted nonmyeloablative allogeneic immunotherapy using HLA mis-matched (3-5/6) related hematopoietic stem cells." November 16, 2003. Link to Item
  - Rizzieri, DA, Sand, GJ, McGaughey, D, Moore, J, DeCastro, C, Chao, N, Vredenburgh, J, Gasparetto, C, Anderson, L, Foster, T, Niedzwiecki, D, and Gockerman, J. "Low-dose weekly paclitaxel for relapsed or refractory aggressive non-Hodgkins lymphoma." November 16, 2003. Link to Item
  - Szabolcs, P, Park, KD, Marti, L, Reese, M, Sanders, L, Niedzwiecki, D, and Kurtzberg, J. "Early T cell reconstitution along with graft and patient characteristics impact on opportunistic infections following unrelated cord blood transplantation in children." April 14, 2003. Link to Item
  - Szabolcs, P, Park, KD, Reese, M, Marti, L, Sanders, L, Niedzwiecki, D, and Kurtzberg, J. "Early T cell reconstitution along with graft and patient characteristics impact on opportunistic infections following unrelated cord blood transplantation in children." November 16, 2002. Link to Item
  - Zhen, S, Dannull, J, Coleman, D, Higgins, J, Yancey, D, Pruitt, S, Weizer, A, Niedzwiecki, D, Gilboa, E, and Vieweg, J. "Immunological and clinical responses in patients with metastatic renal cell carcinoma to vaccination with tumor RNA transfected dendritic cells." November 16, 2002. Link to Item
- Journal Articles
  - Strickler, JH, Loree, JM, Ahronian, LG, Parikh, AR, Niedzwiecki, D, Pereira, AAL, McKinney, M, Korn, WM, Atreya, CE, Banks, KC, Nagy, RJ, Meric-Bernstam, F, Lanman, RB, Talasaz, A, Tsigelny, IF, Corcoran, RB, and Kopetz, S. "Genomic Landscape of Cell-Free DNA in Patients with Colorectal Cancer." Cancer discovery 8, no. 2 (February 2018): 164-173. Full Text
  - Fuchs, CS, Niedzwiecki, D, Mamon, HJ, Tepper, JE, Ye, X, Swanson, RS, Enzinger, PC, Haller, DG, Dragovich, T, Alberts, SR, Bjarnason, GA, Willett, CG, Gunderson, LL, Goldberg, RM, Venook, AP, Ilson, D, O'Reilly, E, Ciombor, K, Berg, DJ, Meyerhardt, J, and Mayer, RJ. "Adjuvant Chemoradiotherapy With Epirubicin, Cisplatin, and Fluorouracil Compared With Adjuvant Chemoradiotherapy With Fluorouracil and Leucovorin After Curative Resection of Gastric Cancer: Results From CALGB 80101 (Alliance)." Journal of clinical oncology : official journal of the American Society of Clinical Oncology 35, no. 32 (November 2017): 3671-3677. Full Text
  - Ronellenfitsch, U, Schwarzbach, M, Hofheinz, R, Kienle, P, Nowak, K, Kieser, M, Slanger, TE, Burmeister, B, Kelsen, D, Niedzwiecki, D, Schuhmacher, C, Urba, S, van de Velde, C, Walsh, TN, Ychou, M, and Jensen, K. "Predictors of overall and recurrence-free survival after neoadjuvant chemotherapy for gastroesophageal adenocarcinoma: Pooled analysis of individual patient data (IPD) from randomized controlled trials (RCTs)." European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 43, no. 8 (August 2017): 1550-1558. Full Text
  - Erhunmwunsee, L, Gulack, BC, Rushing, C, Niedzwiecki, D, Berry, MF, and Hartwig, MG. "Socioeconomic Status, Not Race, Is Associated With Reduced Survival in Esophagectomy Patients." The Annals of thoracic surgery 104, no. 1 (July 2017): 234-244. Full Text
  - Fuchs, MA, Yuan, C, Sato, K, Niedzwiecki, D, Ye, X, Saltz, LB, Mayer, RJ, Mowat, RB, Whittom, R, Hantel, A, Benson, A, Atienza, D, Messino, M, Kindler, H, Venook, A, Innocenti, F, Warren, RS, Bertagnolli, MM, Ogino, S, Giovannucci, EL, Horvath, E, Meyerhardt, JA, and Ng, K. "Predicted vitamin D status and colon cancer recurrence and mortality in CALGB 89803 (Alliance)." Annals of oncology : official journal of the European Society for Medical Oncology 28, no. 6 (June 2017): 1359-1367. Full Text
  - Venook, AP, Niedzwiecki, D, Lenz, H-J, Innocenti, F, Fruth, B, Meyerhardt, JA, Schrag, D, Greene, C, O'Neil, BH, Atkins, JN, Berry, S, Polite, BN, O'Reilly, EM, Goldberg, RM, Hochster, HS, Schilsky, RL, Bertagnolli, MM, El-Khoueiry, AB, Watson, P, Benson, AB, Mulkerin, DL, Mayer, RJ, and Blanke, C. "Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With KRAS Wild-Type Advanced or Metastatic Colorectal Cancer: A Randomized Clinical Trial." JAMA 317, no. 23 (June 2017): 2392-2401. Full Text
  - Niedzwiecki, D, Frankel, WL, Venook, AP, Ye, X, Friedman, PN, Goldberg, RM, Mayer, RJ, Colacchio, TA, Mulligan, JM, Davison, TS, O'Brien, E, Kerr, P, Johnston, PG, Kennedy, RD, Harkin, DP, Schilsky, RL, Bertagnolli, MM, Warren, RS, and Innocenti, F. "Reply to L. Casadaban et al." Journal of clinical oncology : official journal of the American Society of Clinical Oncology 35, no. 12 (April 2017): 1373-1374. Full Text
  - Riedel, RF, Meadows, KL, Lee, PH, Morse, MA, Uronis, HE, Blobe, GC, George, DJ, Crawford, J, Niedzwiecki, D, Rushing, CN, Arrowood, CC, and Hurwitz, HI. "Phase I study of pazopanib plus TH-302 in advanced solid tumors." Cancer chemotherapy and pharmacology 79, no. 3 (March 2017): 611-619. Full Text
  - Niedzwiecki, D, Hasson, RM, Lenz, H-J, Ye, C, Redston, M, Ogino, S, Fuchs, CS, Compton, CC, Mayer, RJ, Goldberg, RM, Colacchio, TA, Saltz, LB, Warren, RS, and Bertagnolli, MM. "A Study of Thymidylate Synthase Expression as a Biomarker for Resectable Colon Cancer: Alliance (Cancer and Leukemia Group B) 9581 and 89803." The oncologist 22, no. 1 (January 2017): 107-114. Full Text
  - Hatch, AJ, Sibley, AB, Starr, MD, Brady, JC, Jiang, C, Jia, J, Bowers, DL, Pang, H, Owzar, K, Niedzwiecki, D, Innocenti, F, Venook, AP, Hurwitz, HI, Nixon, AB, and Alliance for Clinical Trials in Oncology, . "Blood-based markers of efficacy and resistance to cetuximab treatment in metastatic colorectal cancer: results from CALGB 80203 (Alliance)." Cancer medicine 5, no. 9 (September 2016): 2249-2260. Full Text
  - Niedzwiecki, D, Frankel, WL, Venook, AP, Ye, X, Friedman, PN, Goldberg, RM, Mayer, RJ, Colacchio, TA, Mulligan, JM, Davison, TS, O'Brien, E, Kerr, P, Johnston, PG, Kennedy, RD, Harkin, DP, Schilsky, RL, Bertagnolli, MM, Warren, RS, and Innocenti, F. "Association Between Results of a Gene Expression Signature Assay and Recurrence-Free Interval in Patients With Stage II Colon Cancer in Cancer and Leukemia Group B 9581 (Alliance)." Journal of clinical oncology : official journal of the American Society of Clinical Oncology 34, no. 25 (September 2016): 3047-3053. Full Text
  - Enzinger, PC, Burtness, BA, Niedzwiecki, D, Ye, X, Douglas, K, Ilson, DH, Villaflor, VM, Cohen, SJ, Mayer, RJ, Venook, A, Benson, AB, and Goldberg, RM. "CALGB 80403 (Alliance)/E1206: A Randomized Phase II Study of Three Chemotherapy Regimens Plus Cetuximab in Metastatic Esophageal and Gastroesophageal Junction Cancers." Journal of clinical oncology : official journal of the American Society of Clinical Oncology 34, no. 23 (August 2016): 2736-2742. Full Text
  - Hochster, HS, and Niedzwiecki, D. "Big Data, Small Effects." Journal of clinical oncology : official journal of the American Society of Clinical Oncology 34, no. 11 (April 2016): 1170-1171. Full Text
  - Kulke, MH, Niedzwiecki, D, Foster, NR, Fruth, B, Kunz, PL, Kennecke, H, Wolin, EM, and Venook, AP. "Randomized Phase II Study of Everolimus (E) Versus Everolimus plus Bevacizumab (E plus B) in Patients (Pts) With Locally Advanced or Metastatic Pancreatic Neuroendocrine Tumors (pNET), CALGB 80701 (Alliance)." PANCREAS 45, no. 3 (March 2016): 477-477. Link to Item
  - Guercio, BJ, Sato, K, Niedzwiecki, D, Ye, X, Saltz, LB, Mayer, RJ, Mowat, RB, Whittom, R, Hantel, A, Benson, A, Atienza, D, Messino, M, Kindler, H, Venook, A, Hu, FB, Ogino, S, Wu, K, Willett, WC, Giovannucci, EL, Meyerhardt, JA, and Fuchs, CS. "Coffee Intake, Recurrence, and Mortality in Stage III Colon Cancer: Results From CALGB 89803 (Alliance)." Journal of clinical oncology : official journal of the American Society of Clinical Oncology 33, no. 31 (November 2015): 3598-3607. Full Text
  - Meadows, KL, Rushing, C, Honeycutt, W, Latta, K, Howard, L, Arrowood, CA, Niedzwiecki, D, and Hurwitz, HI. "Treatment of palmar-plantar erythrodysesthesia (PPE) with topical sildenafil: a pilot study." Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 23, no. 5 (May 2015): 1311-1319. Full Text
  - Cushman, SM, Jiang, C, Hatch, AJ, Shterev, I, Sibley, AB, Niedzwiecki, D, Venook, AP, Owzar, K, Hurwitz, HI, and Nixon, AB. "Gene expression markers of efficacy and resistance to cetuximab treatment in metastatic colorectal cancer: results from CALGB 80203 (Alliance)." Clinical cancer research : an official journal of the American Association for Cancer Research 21, no. 5 (March 2015): 1078-1086. Full Text
  - Meadows, KL, Rushing, C, Honeycutt, W, Latta, K, Howard, L, Arrowood, CA, Niedzwiecki, D, and Hurwitz, HI. "Treatment of palmar-plantar erythrodysesthesia (PPE) with topical sildenafil: a pilot study." Supportive Care in Cancer 23, no. 5 (2015): 1311-1319. Full Text
  - Ng, K, Meyerhardt, JA, Chan, AT, Sato, K, Chan, JA, Niedzwiecki, D, Saltz, LB, Mayer, RJ, Benson, AB, Schaefer, PL, Whittom, R, Hantel, A, Goldberg, RM, Venook, AP, Ogino, S, Giovannucci, EL, and Fuchs, CS. "Aspirin and COX-2 inhibitor use in patients with stage III colon cancer." Journal of the National Cancer Institute 107, no. 1 (January 2015): 345-. Full Text
  - Renfro, LA, Grothey, AM, Paul, J, Floriani, I, Bonnetain, F, Niedzwiecki, D, Yamanaka, T, Souglakos, I, Yothers, G, and Sargent, DJ. "Projecting Event-Based Analysis Dates in Clinical Trials: An Illustration Based on the International Duration Evaluation of Adjuvant Chemotherapy (IDEA) Collaboration. Projecting analysis dates for the IDEA collaboration." Forum of clinical oncology 5, no. 2 (December 10, 2014): 1-7. Full Text
  - Shiovitz, S, Bertagnolli, MM, Renfro, LA, Nam, E, Foster, NR, Dzieciatkowski, S, Luo, Y, Lao, VV, Monnat, RJ, Emond, MJ, Maizels, N, Niedzwiecki, D, Goldberg, RM, Saltz, LB, Venook, A, Warren, RS, Grady, WM, and Alliance for Clinical Trials in Oncology, . "CpG island methylator phenotype is associated with response to adjuvant irinotecan-based therapy for stage III colon cancer." Gastroenterology 147, no. 3 (September 2014): 637-645. Full Text
  - Shiovitz, S, Bertagnolli, MM, Renfro, LA, Nam, E, Foster, NR, Dzieciatkowski, S, Luo, Y, Lao, VV, Monnat, RJ, Emond, MJ, Maizels, N, Niedzwiecki, D, Goldberg, RM, Saltz, LB, Venook, A, Warren, RS, and Grady, WM. "CpG Island Methylator Phenotype Is Associated With Response to Adjuvant Irinotecan-Based Therapy for Stage III Colon Cancer." Gastroenterology 147, no. 3 (September 2014): 637-645. Full Text
  - Van Loon, K, Owzar, K, Jiang, C, Kindler, HL, Mulcahy, MF, Niedzwiecki, D, O'Reilly, EM, Fuchs, C, Innocenti, F, Venook, AP, and Alliance for Clinical Trials in Oncology, . "25-Hydroxyvitamin D levels and survival in advanced pancreatic cancer: findings from CALGB 80303 (Alliance)." JNCI Journal of the National Cancer Institute 106, no. 8 (August 6, 2014). Full Text
  - Venook, AP, Niedzwiecki, D, Lenz, H-J, Innocenti, F, Mahoney, MR, O'Neil, BH, Shaw, JE, Polite, BN, Hochster, HS, Atkins, JN, Goldberg, RM, Mayer, RJ, Schilsky, RL, Bertagnolli, MM, David, C, Blanke, CD, Alliance, CLGB, SWOG, , and ECOG, . "CALGB/SWOG 80405: Phase III trial of irinotecan/5-FU/leucovorin (FOLFIRI) or oxaliplatin/5-FU/leucovorin (mFOLFOX6) with bevacizumab (BV) or cetuximab (CET) for patients (pts) with KRAS wild-type (wt) untreated metastatic adenocarcinoma of the colon or rectum (MCRC)." JOURNAL OF CLINICAL ONCOLOGY 32, no. 18 (June 20, 2014). Link to Item
  - Parikh, SH, Mendizabal, A, Benjamin, CL, Komanduri, KV, Antony, J, Petrovic, A, Hale, G, Driscoll, TA, Martin, PL, Page, KM, Flickinger, K, Moffet, J, Niedzwiecki, D, Kurtzberg, J, and Szabolcs, P. "A novel reduced-intensity conditioning regimen for unrelated umbilical cord blood transplantation in children with nonmalignant diseases." Biol Blood Marrow Transplant 20, no. 3 (March 2014): 326-336. Full Text Link to Item
  - Parikh, SH, Mendizabal, A, Benjamin, CL, Komanduri, KV, Antony, J, Petrovic, A, Hale, G, Driscoll, TA, Martin, PL, Page, KM, Flickinger, K, Moffet, J, Niedzwiecki, D, Kurtzberg, J, and Szabolcs, P. "A novel reduced-intensity conditioning regimen for unrelated umbilical cord blood transplantation in children with nonmalignant diseases." Biology of Blood and Marrow Transplantation 20, no. 3 (March 1, 2014): 326-336. Full Text
  - Fuchs, MA, Sato, K, Niedzwiecki, D, Ye, X, Saltz, LB, Mayer, RJ, Mowat, RB, Whittom, R, Hantel, A, Benson, A, Atienza, D, Messino, M, Kindler, H, Venook, A, Ogino, S, Wu, K, Willett, WC, Giovannucci, EL, and Meyerhardt, JA. "Sugar-sweetened beverage intake and cancer recurrence and survival in CALGB 89803 (Alliance)." PloS one 9, no. 6 (January 2014): e99816-. Full Text
  - Parikh, SH, Mendizabal, A, Benjamin, CL, Komanduri, KV, Antony, J, Petrovic, A, Hale, G, Driscoll, TA, Martin, PL, Page, KM, Flickinger, K, Moffet, J, Niedzwiecki, D, Kurtzberg, J, and Szabolcs, P. "A novel reduced-intensity conditioning regimen for unrelated umbilical cord blood transplantation in children with nonmalignant diseases." Biology of Blood and Marrow Transplantation 20, no. 3 (2014): 326-336.
  - Pavelitz, T, Renfro, L, Foster, NR, Caracol, A, Welsch, P, Lao, VV, Grady, WB, Niedzwiecki, D, Saltz, LB, Bertagnolli, MM, Goldberg, RM, Rabinovitch, PS, Emond, M, Monnat, RJ, and Maizels, N. "MRE11-deficiency associated with improved long-term disease free survival and overall survival in a subset of stage III colon cancer patients in randomized CALGB 89803 trial." PloS one 9, no. 10 (January 2014): e108483-. Full Text
  - Ogino, S, Liao, X, Imamura, Y, Yamauchi, M, McCleary, NJ, Ng, K, Niedzwiecki, D, Saltz, LB, Mayer, RJ, Whittom, R, Hantel, A, Benson, AB, Mowat, RB, Spiegelman, D, Goldberg, RM, Bertagnolli, MM, Meyerhardt, JA, Fuchs, CS, and Alliance for Clinical Trials in Oncology, . "Predictive and prognostic analysis of PIK3CA mutation in stage III colon cancer intergroup trial." J Natl Cancer Inst 105, no. 23 (December 4, 2013): 1789-1798. Full Text Link to Item
  - Jeon, J, Sato, K, Niedzwiecki, D, Ye, X, Saltz, LB, Mayer, RJ, Mowat, RB, Whittom, R, Hantel, A, Benson, A, Wigler, DS, Atienza, D, Messino, M, Kindler, H, Venook, A, Fuchs, CS, and Meyerhardt, JA. "Impact of physical activity after cancer diagnosis on survival in patients with recurrent colon cancer: Findings from CALGB 89803/alliance." Clinical Colorectal Cancer 12, no. 4 (December 1, 2013): 233-238. Full Text
  - Morse, MA, Niedzwiecki, D, Marshall, JL, Garrett, C, Chang, DZ, Aklilu, M, Crocenzi, TS, Cole, DJ, Dessureault, S, Hobeika, AC, Osada, T, Onaitis, M, Clary, BM, Hsu, D, Devi, GR, Bulusu, A, Annechiarico, RP, Chadaram, V, Clay, TM, and Lyerly, HK. "A randomized phase II study of immunization with dendritic cells modified with poxvectors encoding CEA and MUC1 compared with the same poxvectors plus GM-CSF for resected metastatic colorectal cancer." Annals of Surgery 258, no. 6 (December 1, 2013): 879-886. Full Text
  - Morse, MA, Niedzwiecki, D, Marshall, JL, Garrett, C, Chang, DZ, Aklilu, M, Crocenzi, TS, Cole, DJ, Dessureault, S, Hobeika, AC, Osada, T, Onaitis, M, Clary, BM, Hsu, D, Devi, GR, Bulusu, A, Annechiarico, RP, Chadaram, V, Clay, TM, and Lyerly, HK. "A randomized phase II study of immunization with dendritic cells modified with poxvectors encoding CEA and MUC1 compared with the same poxvectors plus GM-CSF for resected metastatic colorectal cancer." Ann Surg 258, no. 6 (December 2013): 879-886. Full Text Link to Item
  - Warren, RS, Atreya, CE, Niedzwiecki, D, Weinberg, VK, Donner, DB, Mayer, RJ, Goldberg, RM, Compton, CC, Zuraek, MB, Ye, C, Saltz, LB, and Bertagnolli, MM. "Association of TP53 mutational status and gender with survival after adjuvant treatment for stage III colon cancer: results of CALGB 89803." Clin Cancer Res 19, no. 20 (October 15, 2013): 5777-5787. Full Text Link to Item
  - Van Loon, K, Wigler, D, Niedzwiecki, D, Venook, AP, Fuchs, C, Blanke, C, Saltz, L, Goldberg, RM, and Meyerhardt, JA. "Comparison of Dietary. and Lifestyle Habits Among Stage III and Metastatic Colorectal Cancer Patients: Findings from CALGB 89803 and CALGB 80405." CLINICAL COLORECTAL CANCER 12, no. 2 (June 2013): 95-102. Full Text Link to Item
  - Venook, AP, Niedzwiecki, D, Lopatin, M, Ye, X, Lee, M, Friedman, PN, Frankel, W, Clark-Langone, K, Millward, C, Shak, S, Goldberg, RM, Mahmoud, NN, Warren, RS, Schilsky, RL, and Bertagnolli, MM. "Biologic determinants of tumor recurrence in stage II colon cancer: validation study of the 12-gene recurrence score in cancer and leukemia group B (CALGB) 9581." J Clin Oncol 31, no. 14 (May 10, 2013): 1775-1781. Full Text Link to Item
  - Jeon, J, Sato, K, Niedzwiecki, D, Ye, X, Saltz, LB, Mayer, RJ, Mowat, RB, Whittom, R, Hantel, A, Benson, A, Wigler, DS, Atienza, D, Messino, M, Kindler, H, Venook, A, Fuchs, CS, and Meyerhardt, JA. "Impact of Physical Activity After Cancer Diagnosis on Survival in Patients With Recurrent Colon Cancer: Findings From CALGB 89803/Alliance." Clinical Colorectal Cancer (2013).
  - Ronellenfitsch, U, Schwarzbach, M, Hofheinz, R, Kienle, P, Kieser, M, Slanger, TE, Burmeister, B, Kelsen, D, Niedzwiecki, D, Schuhmacher, C, Urba, S, Velde, CVD, Walsh, TN, Ychou, M, and Jensen, K. "Preoperative chemo(radio)therapy versus primary surgery for gastroesophageal adenocarcinoma: Systematic review with meta-analysis combining individual patient and aggregate data." European Journal of Cancer 49, no. 15 (2013): 3149-3158. Full Text
  - Ronellenfitsch, U, Schwarzbach, M, Hofheinz, R, Kienle, P, Kieser, M, Slanger, TE, Burmeister, B, Kelsen, D, Niedzwiecki, D, Schuhmacher, C, and al, E. "Preoperative chemo(radio)therapy versus primary surgery for gastroesophageal adenocarcinoma: Systematic review with meta-analysis combining individual patient and aggregate data." European Journal of Cancer (2013). Full Text
  - Ronellenfitsch, U, Schwarzbach, M, Hofheinz, R, Kienle, P, Kieser, M, Slanger, TE, Jensen, K, and GE Adenocarcinoma Meta‐analysis Group, . "Perioperative chemo(radio)therapy versus primary surgery for resectable adenocarcinoma of the stomach, gastroesophageal junction, and lower esophagus." The Cochrane database of systematic reviews , no. 5 (January 2013): CD008107-. (Review) Full Text
  - Gajewski, TF, Salama, AKS, Niedzwiecki, D, Johnson, J, Linette, G, Bucher, C, Blaskovich, MA, Sebti, SM, Haluska, F, and Canc, LGB. "Phase II study of the farnesyltransferase inhibitor R115777 in advanced melanoma (CALGB 500104)." JOURNAL OF TRANSLATIONAL MEDICINE 10 (December 10, 2012). Full Text Link to Item
  - Kanda, J, Chiou, L-W, Szabolcs, P, Sempowski, GD, Rizzieri, DA, Long, GD, Sullivan, KM, Gasparetto, C, Chute, JP, Morris, A, McPherson, J, Hale, J, Livingston, JA, Broadwater, G, Niedzwiecki, D, Chao, NJ, and Horwitz, ME. "Immune recovery in adult patients after myeloablative dual umbilical cord blood, matched sibling, and matched unrelated donor hematopoietic cell transplantation." Biol Blood Marrow Transplant 18, no. 11 (November 2012): 1664-1676.e1. Full Text Link to Item
  - Osada, T, Berglund, P, Morse, MA, Hubby, B, Lewis, W, Niedzwiecki, D, Yang, XY, Hobeika, A, Burnett, B, Devi, GR, Clay, TM, Smith, J, and Kim Lyerly, H. "Co-delivery of antigen and IL-12 by Venezuelan equine encephalitis virus replicon particles enhances antigen-specific immune responses and antitumor effects." Cancer Immunol Immunother 61, no. 11 (November 2012): 1941-1951. Full Text Link to Item
  - Hasson, RM, Niedzwiecki, D, and Bertagnolli, MM. "Abstract 4514: A comparison of two methodologies to quantify Thymidylate synthase for predicting survival in patients with colorectal cancer treated on CALGB 89803." Cancer Research 72, no. 8 Supplement (April 15, 2012): 4514-4514. Full Text
  - Atreya, CE, Warren, RS, Niedzwiecki, D, Mayer, RJ, Goldberg, RM, Compton, CC, Zuraek, M, Bergsland, EK, Ye, C, Weinberg, VK, and Bertagnolli, MM. "A novel interaction of genotype, gender, and adjuvant treatment in survival after resection of stage III colon cancer: Results of CALGB 89803." Journal of clinical oncology : official journal of the American Society of Clinical Oncology 30, no. 4_suppl (February 2012): 452-.
  - Meyerhardt, JA, Sato, K, Niedzwiecki, D, Ye, C, Saltz, LB, Mayer, RJ, Mowat, RB, Whittom, R, Hantel, A, Benson, A, Wigler, DS, Venook, A, and Fuchs, CS. "Dietary glycemic load and cancer recurrence and survival in patients with stage III colon cancer: Findings from CALGB 89803." Journal of the National Cancer Institute 104, no. 22 (2012): 1702-1711. Full Text
  - Romanus, D, Kindler, HL, Archer, L, Basch, E, Niedzwiecki, D, Weeks, J, and Schrag, D. "Does health-related quality of life improve for advanced pancreatic cancer patients who respond to gemcitabine? Analysis of a randomized phase III trial of the cancer and leukemia group B (CALGB 80303)." Journal of Pain and Symptom Management 43, no. 2 (2012): 205-217. Full Text
  - Niedzwiecki, D, Bertagnolli, MM, Warren, RS, Compton, CC, Kemeny, NE, Benson, AB, Eckhardt, SG, Alberts, S, Porjosh, GN, Kerr, DJ, Fields, A, Rougier, P, Pipas, JM, Schwartz, JH, Atkins, J, O'Rourke, M, Perry, MC, Goldberg, RM, Mayer, RJ, and Colacchio, TA. "Documenting the natural history of patients with resected stage II adenocarcinoma of the colon after random assignment to adjuvant treatment with edrecolomab or observation: results from CALGB 9581." J Clin Oncol 29, no. 23 (August 10, 2011): 3146-3152. Full Text Link to Item
  - Kanda, J, Rizzieri, DA, Gasparetto, C, Long, GD, Chute, JP, Sullivan, KM, Morris, A, Smith, CA, Hogge, DE, Nitta, J, Song, K, Niedzwiecki, D, Chao, NJ, and Horwitz, ME. "Adult dual umbilical cord blood transplantation using myeloablative total body irradiation (1350 cGy) and fludarabine conditioning." Biol Blood Marrow Transplant 17, no. 6 (June 2011): 867-874. Full Text Link to Item
  - Fuchs, CS, Tepper, JE, Niedzwiecki, D, Hollis, D, Mamon, HJ, Swanson, R, Haller, DG, Dragovich, T, Alberts, SR, Bjarnason, GA, Willett, CG, Enzinger, PC, Goldberg, RM, Venook, AP, and Mayer, RJ. "Postoperative adjuvant chemoradiation for gastric or gastroesophageal junction (GEJ) adenocarcinoma using epirubicin, cisplatin, and infusional (CI) 5-FU (ECF) before and after CI 5-FU and radiotherapy (CRT) compared with bolus 5-FU/LV before and after CRT: Intergroup trial CALGB 80101." Journal of Clinical Oncology 29, no. 15_suppl (May 20, 2011): 4003-4003. Full Text
  - Van Loon, K, Wigler, D, Niedzwiecki, D, Hollis, D, Venook, AP, Blanke, CD, Saltz, L, Goldberg, RM, Fuchs, CS, and Meyerhardt, JA. "A comparison of dietary and lifestyle habits among stage III and metastatic colorectal cancer patients." Journal of Clinical Oncology 29, no. 15_suppl (May 20, 2011): e14026-e14026. Full Text
  - Venook, AP, Niedzwiecki, D, Lopatin, M, Lee, M, Friedman, PN, Frankel, W, Clark-Langone, K, Yoshizawa, C, Millward, C, Shak, S, Goldberg, RM, Mahmoud, NN, Schilsky, RL, Bertagnolli, MM, and Canc, LGB. "Validation of a 12-gene colon cancer recurrence score (RS) in patients (pts) with stage II colon cancer (CC) from CALGB 9581." JOURNAL OF CLINICAL ONCOLOGY 29, no. 15 (May 20, 2011). Link to Item
  - Fuchs, CS, Tepper, JE, Niedzwiecki, D, Hollis, D, Mamon, HJ, Swanson, R, Haller, DG, Dragovich, T, Alberts, SR, Bjarnason, GA, Willett, CG, Enzinger, PC, Goldberg, RM, Venook, AP, and Mayer, RJ. "Postoperative adjuvant chemoradiation for gastric or gastroesophageal junction (GEJ) adenocarcinoma using epirubicin, cisplatin, and infusional (CI) 5-FU (ECF) before and after CI 5-FU and radiotherapy (CRT) compared with bolus 5-FU/LV before and after CRT: Intergroup trial CALGB 80101." Journal of clinical oncology : official journal of the American Society of Clinical Oncology 29, no. 15_suppl (May 2011): 4003-.
  - Lyerly, HK, Hobeika, A, Niedzwiecki, D, Osada, T, Marshall, J, Garrett, CR, Chang, DZ, Aklilu, M, Crocenzi, TS, Cole, DJ, Dessureault, S, Hsu, SD, Bulusu, A, Clary, BM, Annechiarico, R, Devi, G, Chadaram, V, Clay, TM, and Morse, M. "A dendritic cell-based vaccine effects on T-cell responses compared with a viral vector vaccine when administered to patients following resection of colorectal metastases in a randomized phase II study." Journal of clinical oncology : official journal of the American Society of Clinical Oncology 29, no. 15_suppl (May 2011): 2533-.
  - Morse, M, Niedzwiecki, D, Marshall, J, Garrett, CR, Chang, DZ, Aklilu, M, Crocenzi, TS, Cole, DJ, Dessureault, S, Hobeika, A, Osada, T, Clary, BM, Hsu, SD, Devi, G, Bulusu, A, Annechiarico, R, Chadaram, V, Clay, TM, and Lyerly, HK. "Survival rates among patients vaccinated following resection of colorectal cancer metastases in a phase II randomized study compared with contemporary controls." Journal of clinical oncology : official journal of the American Society of Clinical Oncology 29, no. 15_suppl (May 2011): 3557-.
  - Van Loon, K, Wigler, D, Niedzwiecki, D, Hollis, D, Venook, AP, Blanke, CD, Saltz, L, Goldberg, RM, Fuchs, CS, and Meyerhardt, JA. "A comparison of dietary and lifestyle habits among stage III and metastatic colorectal cancer patients." Journal of clinical oncology : official journal of the American Society of Clinical Oncology 29, no. 15_suppl (May 2011): e14026-.
  - Venook, AP, Niedzwiecki, D, Lopatin, M, Lee, M, Friedman, PN, Frankel, W, Clark-Langone, K, Yoshizawa, C, Millward, C, Shak, S, Goldberg, RM, Mahmoud, NN, Schilsky, RL, and Bertagnolli, MM. "Validation of a 12-gene colon cancer recurrence score (RS) in patients (pts) with stage II colon cancer (CC) from CALGB 9581." Journal of clinical oncology : official journal of the American Society of Clinical Oncology 29, no. 15_suppl (May 2011): 3518-.
  - Bertagnolli, MM, Redston, M, Compton, CC, Niedzwiecki, D, Mayer, RJ, Goldberg, RM, Colacchio, TA, Saltz, LB, and Warren, RS. "Microsatellite instability and loss of heterozygosity at chromosomal location 18q: Pospective evaluation of biomarkers for stages II and III colon cancer - A study of CALGB 9581 and 89803." Journal of Clinical Oncology 29, no. 23 (2011): 3153-3162. Full Text
  - Mamon, HJ, Niedzwiecki, D, Hollis, D, Tan, BR, Mayer, RJ, Tepper, JE, Goldberg, RM, Blackstock, AW, and Fuchs, CS. "A phase 2 trial of gemcitabine, 5-fluorouracil, and radiation therapy in locally advanced nonmetastatic pancreatic adenocarcinoma." Cancer 117, no. 12 (2011): 2620-2628. Full Text
  - Ng, K, Ogino, S, Meyerhardt, JA, Chan, JA, Chan, AT, Niedzwiecki, D, Hollis, D, Saltz, LB, Mayer, RJ, Benson, AB, Schaefer, PL, Whittom, R, Hantel, A, Goldberg, RM, Bertagnolli, MM, Venook, AP, and Fuchs, CS. "Relationship between statin use and colon cancer recurrence and survival: Results from CALGB 89803." Journal of the National Cancer Institute 103, no. 20 (2011): 1540-1551. Full Text
  - Morse, MA, Hobeika, AC, Osada, T, Berglund, P, Hubby, B, Negri, S, Niedzwiecki, D, Devi, GR, Burnett, BK, Clay, TM, Smith, J, and Lyerly, HK. "An alphavirus vector overcomes the presence of neutralizing antibodies and elevated numbers of Tregs to induce immune responses in humans with advanced cancer." J Clin Invest 120, no. 9 (September 2010): 3234-3241. Full Text Open Access Copy Link to Item
  - Crout, CA, Koh, L-P, Gockerman, JP, Moore, JO, Decastro, C, Long, GD, Diehl, L, Gasparetto, C, Niedzwiecki, D, Edwards, J, Prosnitz, L, Horwitz, M, Chute, J, Morris, A, Davis, P, Beaven, A, Chao, NJ, Ali-Osman, F, and Rizzieri, DA. "Overcoming drug resistance in mantle cell lymphoma using a combination of dose-dense and intense therapy." Cancer Invest 28, no. 6 (July 2010): 654-660. Full Text Link to Item
  - Enzinger, PC, Burtness, B, Hollis, D, Niedzwiecki, D, Ilson, D, Benson, AB, Mayer, RJ, and Goldberg, RM. "A randomized phase II study of three standard chemotherapy regimens (ECF, IC, FOLFOX) plus cetuximab in metastatic esophageal and GE junction cancer." JOURNAL OF CLINICAL ONCOLOGY 28, no. 15 (May 20, 2010). Link to Item
  - Kaiser, LD, Melemed, AS, Preston, AJ, Ross, HAC, Niedzwiecki, D, Fyfe, GA, Gough, JM, Bushnell, WD, Stephens, CL, Mace, MK, Abrams, JS, and Schilsky, RL. "Optimizing collection of adverse event data in cancer clinical trials supporting supplemental indications." Journal of Clinical Oncology 28, no. 34 (2010): 5046-5053. Full Text
  - Kindler, HL, Niedzwiecki, D, Hollis, D, Sutherland, S, Schrag, D, Hurwitz, H, Innocenti, F, Mulcahy, MF, O'Reilly, E, Wozniak, TF, Picus, J, Bhargava, P, Mayer, RJ, Schilsky, RL, and Goldberg, RM. "Gemcitabine plus bevacizumab compared with gemcitabine plus placebo in patients with advanced pancreatic cancer: Phase III trial of the Cancer and Leukemia Group B (CALGB 80303)." Journal of Clinical Oncology 28, no. 22 (2010): 3617-3622. Full Text
  - McCleary, NJ, Niedzwiecki, D, Hollis, D, Saltz, LB, Schaefer, P, Whittom, R, Hantel, A, Benson, A, Goldberg, R, and Meyerhardt, JA. "Impact of smoking on patients with stage iii colon cancer: Results from cancer and leukemia group B 89803." Cancer 116, no. 4 (2010): 957-966. Full Text
  - Ng, K, Meyerhardt, JA, Chan, JA, Niedzwiecki, D, Hollis, DR, Saltz, LB, Mayer, RJ, III, ABB, Schaefer, PL, Whittom, R, Hantel, A, Goldberg, RM, and Fuchs, CS. "Multivitamin use is not associated with cancer recurrence or survival in patients with stage III colon cancer: Findings from CALGB 89803." Journal of Clinical Oncology 28, no. 28 (2010): 4354-4363. Full Text
  - O'reilly, EM, Niedzwiecki, D, Hall, M, Hollis, D, Bekaii-Saab, T, Pluard, T, Douglas, K, Abou-Alfa, GK, Kindler, HL, Schilsky, RL, and Goldberg, RM. "A Cancer and Leukemia group B phase II study of sunitinib malate in patients with previously treated metastatic pancreatic adenocarcinoma (CALGB 80603)." Oncologist 15, no. 12 (2010): 1310-1319. Full Text
  - Osada, T, Yang, XY, Hartman, ZC, Glass, O, Hodges, BL, Niedzwiecki, D, Morse, MA, Lyerly, HK, Amalfitano, A, and Clay, TM. "Optimization of vaccine responses with an E1, E2b and E3-deleted Ad5 vector circumvents pre-existing anti-vector immunity." Cancer Gene Ther 16, no. 9 (September 2009): 673-682. Full Text Link to Item
  - Bertagnolli, MM, Niedzwiecki, D, Hall, M, Jewell, SD, Mayer, RJ, Goldberg, RM, Colacchio, TA, Warren, RS, and Redston, M. "Presence of 18q loss of heterozygosity (LOH) and disease-free and overall survival in stage II colon cancer: CALGB Protocol 9581." Journal of clinical oncology : official journal of the American Society of Clinical Oncology 27, no. 15_suppl (May 2009): 4012-.
  - Fuchs, C, Ogino, S, Meyerhardt, JA, Irahara, N, Niedzwiecki, D, Hollis, D, Saltz, LB, Mayer, RJ, and Bertagnolli, MM. "KRAS mutation, cancer recurrence, and patient survival in stage III colon cancer: Findings from CALGB 89803." Journal of clinical oncology : official journal of the American Society of Clinical Oncology 27, no. 15_suppl (May 2009): 4037-.
  - Osada, T, Woo, CY, McKinney, M, Yang, XY, Lei, G, Labreche, HG, Hartman, ZC, Niedzwiecki, D, Chao, N, Amalfitano, A, Morse, MA, Lyerly, HK, and Clay, TM. "Induction of Wilms' tumor protein (WT1)-specific antitumor immunity using a truncated WT1-expressing adenovirus vaccine." Clin Cancer Res 15, no. 8 (April 15, 2009): 2789-2796. Full Text Link to Item
  - Bertagnolli, MM, Niedzwiecki, D, Compton, CC, Hahn, HP, Hall, M, Damas, B, Jewell, SD, Mayer, RJ, Goldberg, RM, Saltz, LB, Warren, RS, and Redston, M. "Microsatellite instability predicts improved response to adjuvant therapy with irinotecan, fluorouracil, and leucovorin in stage III colon cancer: Cancer and leukemia group B protocol 89803." Journal of Clinical Oncology 27, no. 11 (2009): 1814-1821. Full Text
  - Bertagnolli, MM, Warren, RS, Niedzwiecki, D, Mueller, E, Compton, CC, Redston, M, Hall, M, Hahn, HP, Jewell, SD, Mayer, RJ, Goldberg, RM, Saltz, LB, and Loda, M. "P27 ^Kip1 in stage III colon cancer: Implications for outcome following adjuvant chemotherapy in cancer and leukemia group B protocol 89803." Clinical Cancer Research 15, no. 6 (2009): 2116-2122. Full Text
  - Canellos, GP, Niedzwiecki, D, and Johnson, JL. "Long-term follow-up of survival in Hodgkin's lymphoma." New England Journal of Medicine 361, no. 24 (2009): 2390-2391. Full Text
  - Damon, LE, Johnson, JL, Niedzwiecki, D, Cheson, BD, Hurd, DD, Bartlett, NL, LaCasce, AS, Blum, KA, Byrd, JC, Kelly, M, Stock, W, Linker, CA, and Canellos, GP. "Immunochemotherapy and autologous stem-cell transplantation for untreated patients with mantle-cell lymphoma: CALGB 59909." Journal of Clinical Oncology 27, no. 36 (2009): 6101-6108. Full Text
  - Kulke, MH, Tempero, MA, Niedzwiecki, D, Hollis, DR, Kindler, HL, Cusnir, M, Enzinger, PC, Gorsch, SM, Goldberg, RM, and Mayer, RJ. "Randomized phase II study of gemcitabine administered at a fixed dose rate or in combination with cisplatin, docetaxel, or irinotecan in patients with metastatic pancreatic cancer: CALGB 89904." Journal of Clinical Oncology 27, no. 33 (2009): 5506-5512. Full Text
  - Ogino, S, Meyerhardt, JA, Irahara, N, Niedzwiecki, D, Hollis, D, Saltz, LB, Mayer, RJ, Schaefer, P, Whittom, R, Hantel, A, III, ABB, Goldberg, RM, Bertagnolli, MM, and Fuchs, CS. "KRAS mutation in stage III colon cancer and clinical outcome following intergroup trial CALGB 89803." Clinical Cancer Research 15, no. 23 (2009): 7322-7329. Full Text
  - Posner, MC, Niedzwiecki, D, Venook, AP, Hollis, DR, Kindler, HL, Martin, EW, Schilsky, RL, Goldberg, RM, and Mayer, RJ. "Erratum: A phase II prospective multi-institutional trial of adjuvant active specific immunotherapy following curative resection of colorectal cancer hepatic metastases: Cancer and leukemia group B study 89903 (Annals of Surgical Oncology (2008) 15 (158-164) DOI: 10.1245/S10434-007-9654-7)." Annals of Surgical Oncology 16, no. 8 (2009): 2381--. Full Text
  - Reddy, SK, Broadwater, G, Niedzwiecki, D, Barbas, AS, Hurwitz, HI, Bendell, JC, Morse, MA, and Clary, BM. "Multiagent chemotherapy for isolated colorectal liver metastases: a single-centered retrospective study." J Gastrointest Surg 13, no. 1 (January 2009): 74-84. Full Text Link to Item
  - Morse, MA, Hobeika, AC, Osada, T, Serra, D, Niedzwiecki, D, Lyerly, HK, and Clay, TM. "Depletion of human regulatory T cells specifically enhances antigen-specific immune responses to cancer vaccines." Blood 112, no. 3 (August 1, 2008): 610-618. Full Text Link to Item
  - Jackson, NA, Fuchs, CS, Niedzwiecki, D, Hollis, DR, Saltz, LB, Mayer, RJ, and Meyerhardt, JA. "The impact of smoking on cancer recurrence and survival in patients with stage III colon cancer: Findings from intergroup trial CALGB 89803." Journal of Clinical Oncology 26, no. 15_suppl (May 20, 2008): 4039-4039. Full Text
  - Jackson, NA, Fuchs, CS, Niedzwiecki, D, Hollis, DR, Saltz, LB, Mayer, RJ, and Meyerhardt, JA. "The impact of smoking on cancer recurrence and survival in patients with stage III colon cancer: Findings from intergroup trial CALGB 89803." J Clin Oncol 26, no. 15_suppl (May 20, 2008): 4039-. Link to Item
  - O'Reilly, EM, Niedzwiecki, D, Hollis, DR, Bekaii-Saab, TS, Pluard, T, Duffy, A, Overcash, F, Ivy, SP, and Goldberg, RM. "A phase II trial of sunitinib (S) in previously-treated pancreas adenocarcinoma (PAC), CALGB 80603." J Clin Oncol 26, no. 15_suppl (May 20, 2008): 4515-. Link to Item
  - O'Reilly, EM, Niedzwiecki, D, Hollis, DR, Bekaii-Saab, TS, Pluard, T, Duffy, A, Overcash, F, Ivy, SP, and Goldberg, RM. "A phase II trial of sunitinib (S) in previously-treated pancreas adenocarcinoma (PAC), CALGB 80603." JOURNAL OF CLINICAL ONCOLOGY 26, no. 15 (May 20, 2008). Link to Item
  - Ocean, AJ, Niedzwiecki, D, Atkins, JN, Parker, B, O'Neil, BH, Lee, JW, Wadler, S, and Goldberg, RM. "LE-SN38 for metastatic colorectal cancer after progression on oxaliplatin: Results of CALGB 80402." J Clin Oncol 26, no. 15_suppl (May 20, 2008): 4109-. Link to Item
  - Ocean, AJ, Niedzwiecki, D, Atkins, JN, Parker, B, O'Neil, BH, Lee, JW, Wadler, S, and Goldberg, RM. "LE-SN38 for metastatic colorectal cancer after progression on oxaliplatin: Results of CALGB 80402." JOURNAL OF CLINICAL ONCOLOGY 26, no. 15 (May 20, 2008). Full Text Link to Item
  - Clay, TM, Hobeika, A, Osada, T, Serra, D, Niedzwiecki, D, Lyerly, HK, and Morse, MA. "Depletion of human regulatory T cells (Treg) and antigen-specific immune responses to cancer vaccines." Journal of clinical oncology : official journal of the American Society of Clinical Oncology 26, no. 15_suppl (May 2008): 3010-.
  - Chan, JA, Meyerhardt, JA, Niedzwiecki, D, Hollis, D, Saltz, LB, Mayer, RJ, Thomas, J, Schaefer, P, Whittom, R, Hantel, A, Goldberg, RM, Warren, RS, Bertagnolli, M, and Fuchs, CS. "Association of family history with cancer recurrence and survival among patients with stage III colon cancer." JAMA - Journal of the American Medical Association 299, no. 21 (2008): 2515-2523. Full Text
  - Hobeika, A, Osada, T, Serra, D, Peplinski, S, Hanson, K, Tanaka, Y, Niedzwiecki, D, Chao, N, Rizzieri, D, Lyerly, H, Clay, T, and Morse, M. "Detailed analysis of cytomegalovirus (CMV)-specific T cells expanded for adoptive immunotherapy of CMV infection following allogeneic stem cell transplantation for malignant disease." Cytotherapy 10, no. 3 (2008): 289-302. Full Text Link to Item
  - Korn, EL, Liu, P-Y, Lee, SJ, Chapman, J-AW, Niedzwiecki, D, Suman, VJ, Moon, J, Sondak, VK, Atkins, MB, Eisenhauer, EA, Parulekar, W, Markovic, SN, Saxman, S, and Kirkwood, JM. "Meta-analysis of phase II cooperative group trials in metastatic stage IV melanoma to determine progression-free and overall survival benchmarks for future phase II trials." Journal of Clinical Oncology 26, no. 4 (2008): 527-534. Full Text
  - Meropol, NJ, Niedzwiecki, D, Shank, B, Colacchio, TA, Ellerton, J, Valone, F, Budinger, S, Day, JM, Hopkins, J, Tepper, J, Goldberg, RM, and Mayer, RJ. "Induction therapy for poor-prognosis anal canal carcinoma: A phase II study of the Cancer and Leukemia Group B (CALGB 9281)." Journal of Clinical Oncology 26, no. 19 (2008): 3229-3234. Full Text
  - Meyerhardt, JA, Niedzwiecki, D, Hollis, D, Saltz, LB, Hu, FB, Mayer, RJ, Nelson, H, Whittom, R, Hantel, A, Thomas, J, and Fuchs, CS. "Association of dietary patterns with cancer recurrence and survival in patients with stage III colon cancer." Obstetrical and Gynecological Survey 63, no. 2 (2008): 94-96. Full Text
  - Meyerhardt, JA, Niedzwiecki, D, Hollis, D, Saltz, LB, Mayer, RJ, Nelson, H, Whittom, R, Hantel, A, Thomas, J, and Fuchs, CS. "Impact of body mass index and weight change after treatment on cancer recurrence and survival in patients with stage III colon cancer: Findings from cancer and leukemia group B 89803." Journal of Clinical Oncology 26, no. 25 (2008): 4109-4115. Full Text
  - Posner, MC, Niedzwiecki, D, Venook, AP, Hollis, DR, Kindler, HL, Martin, EW, Schilsky, RL, and Goldberg, RM. "A phase II prospective multi-institutional trial of adjuvant active specific immunotherapy following curative resection of colorectal cancer hepatic metastases: Cancer and Leukemia Group B study 89903." Annals of Surgical Oncology 15, no. 1 (2008): 158-164. Full Text
  - Smith, SM, Grinblatt, D, Johnson, JL, Niedzwiecki, D, Rizzieri, D, Bartlett, NL, and Cheson, BD. "Thalidomide has limited single-agent activity in relapsed or refractory indolent non-Hodgkin lymphomas: A phase II trial of the Cancer and Leukemia Group B." British Journal of Haematology 140, no. 3 (2008): 313-319. Full Text
  - Szabolcs, P, and Niedzwiecki, D. "Immune reconstitution in children after unrelated cord blood transplantation." Biol Blood Marrow Transplant 14, no. 1 Suppl 1 (January 2008): 66-72. (Review) Full Text Link to Item
  - Tepper, J, Krasna, MJ, Niedzwiecki, D, Hollis, D, Reed, CE, Goldberg, R, Kiel, K, Willett, C, Sugarbaker, D, and Mayer, R. "Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781." Journal of Clinical Oncology 26, no. 7 (2008): 1086-1092. Full Text
  - Tepper, JE, and Niedzwiecki, D. "In reply." Journal of Clinical Oncology 26, no. 31 (2008): 5134--. Full Text
  - Morse, MA, Hobeika, A, Osada, T, Niedzwiecki, D, Marcom, PK, Blackwell, KL, Anders, C, Devi, GR, Lyerly, HK, and Clay, TM. "Long term disease-free survival and T cell and antibody responses in women with high-risk Her2+ breast cancer following vaccination against Her2. (Published online)" J Transl Med 5 (September 6, 2007): 42-. Full Text Link to Item
  - Rizzieri, DA, Koh, LP, Long, GD, Gasparetto, C, Sullivan, KM, Horwitz, M, Chute, J, Smith, C, Gong, JZ, Lagoo, A, Niedzwiecki, D, Dowell, JM, Waters-Pick, B, Liu, C, Marshall, D, Vredenburgh, JJ, Gockerman, J, Decastro, C, Moore, J, and Chao, NJ. "Partially matched, nonmyeloablative allogeneic transplantation: clinical outcomes and immune reconstitution." J Clin Oncol 25, no. 6 (February 20, 2007): 690-697. Full Text Link to Item
  - Ryan, DP, Niedzwiecki, D, Hollis, D, Tepper, J, and Mayer, RJ. "Addition of weekly oxaliplatin to standard preoperative chemoradiation for locally advanced rectal cancer - In reply." JOURNAL OF CLINICAL ONCOLOGY 25, no. 5 (February 10, 2007): 603-603. Full Text Link to Item
  - Bartlett, NL, Niedzwiecki, D, Johnson, JL, Friedberg, JW, Johnson, KB, Besien, KV, Zelenetz, AD, Cheson, BD, and Canellos, GP. "Gemcitabine, vinorelbine, and pegylated liposomal doxorubicin (GVD), a salvage regimen in relapsed Hodgkin's lymphoma: CALGB 59804." Annals of Oncology 18, no. 6 (2007): 1071-1079. Full Text
  - Blum, KA, Johnson, JL, Niedzwiecki, D, Canellos, GP, Cheson, BD, and Bartlett, NL. "Single agent bortezomib in the treatment of relapsed and refractory Hodgkin lymphoma: Cancer and leukemia Group B protocol 50206." Leukemia and Lymphoma 48, no. 7 (2007): 1313-1319. Full Text
  - Czuczman, M, Porcu, P, Johnson, J, Niedzwiecki, D, Kelly, M, Hsi, E, Cook, J, Canellos, G, and Cheson, B. "Results of a phase II study of 506U78 in cutaneous T-cell lymphoma and peripheral T-cell lymphoma: CALGB 59901." Leukemia and Lymphoma 48, no. 1 (2007): 97-103. Full Text
  - Goel, A, Nagasaka, T, Arnold, CN, Inoue, T, Hamilton, C, Niedzwiecki, D, Compton, C, Mayer, RJ, Goldberg, R, Bertagnolli, MM, and Boland, CR. "The CpG Island Methylator Phenotype and Chromosomal Instability Are Inversely Correlated in Sporadic Colorectal Cancer." Gastroenterology 132, no. 1 (2007): 127-138. Full Text
  - Meyerhardt, JA, Niedzwiecki, D, Hollis, D, Saltz, LB, Hu, FB, Mayer, RJ, Nelson, H, Whittom, R, Hantel, A, Thomas, J, and Fuchs, CS. "Association of dietary patterns with cancer recurrence and survival in patients with stage III colon cancer." Journal of the American Medical Association 298, no. 7 (2007): 754-764. Full Text
  - Ryan, DP, Niedzwiecki, D, Hollis, D, Tepper, J, and Mayer, RJ. "In reply [2]." Journal of Clinical Oncology 25, no. 5 (2007): 603--.
  - Saltz, LB, Niedzwiecki, D, Hollis, D, Goldberg, RM, Hantel, A, Thomas, JP, Fields, ALA, and Mayer, RJ. "Irinotecan fluorouracil plus leucovorin is not superior to fluorouracil plus leucovorin alone as adjuvant treatment for stage III colon cancer: Results of CALGB 89803." Journal of Clinical Oncology 25, no. 23 (2007): 3456-3461. Full Text
  - Szabolcs, P, and Niedzwiecki, D. "Immune reconstitution after unrelated cord blood transplantation." Cytotherapy 9, no. 2 (2007): 111-122. (Review) Full Text Link to Item
  - Venook, AP, Blanke, CD, Niedzwiecki, D, Lenz, H-J, Taylor, JR, Hollis, DR, Sutherland, S, and Goldberg, RM. "Revisiting the Cancer and Leukemia Group B/Southwest Oncology Group 80405 trial: A phase III trial of chemotherapy and biologic agents for patients with untreated advanced colorectal adenocarcinoma." Clinical Colorectal Cancer 6, no. 7 (2007): 536-538. Full Text
  - Bosworth, HB, Rockey, DC, Paulson, EK, Niedzwiecki, D, Davis, W, Sanders, LL, Yee, J, Henderson, J, Hatten, P, Burdick, S, Sanyal, A, Rubin, DT, Sterling, M, Akerkar, G, Bhutani, MS, Binmoeller, K, Garvie, J, Bini, EJ, McQuaid, K, Foster, WL, Thompson, WM, Dachman, A, and Halvorsen, R. "Prospective comparison of patient experience with colon imaging tests." The American journal of medicine 119, no. 9 (September 2006): 791-799. (Academic Article) Full Text
  - Bertagnolli, MM, Compton, CC, Niedzwiecki, D, Warren, RS, Jewell, S, Bailey, GP, Mayer, RJ, Goldberg, R, Saltz, L, and Redston, M. "Microsatellite instability predicts improved response to adjuvant therapy with irinotecan, 5-fluorouracil and leucovorin in stage III colon cancer." J Clin Oncol 24, no. 18_suppl (June 20, 2006): 10003-. Link to Item
  - Blum, KA, Johnson, JL, Niedzwiecki, D, Cannellos, GP, Cheson, BD, and Bartlett, NL. "A phase II study of bortezomib in relapsed Hodgkin lymphoma: Preliminary results of CALGB 50206." J Clin Oncol 24, no. 18_suppl (June 20, 2006): 7576-. Link to Item
  - Gajewski, TF, Niedzwiecki, D, Johnson, J, Linette, G, Bucher, C, Blaskovich, M, Sebti, S, and Haluska, F. "Phase II study of the farnesyltransferase inhibitor R115777 in advanced melanoma: CALGB 500104." J Clin Oncol 24, no. 18_suppl (June 20, 2006): 8014-. Link to Item
  - Tepper, JE, Krasna, M, Niedzwiecki, D, Hollis, D, Reed, C, Goldberg, R, Rich, T, Kiel, K, and Mayer, R. "Superiority of trimodality therapy to surgery alone in esophageal cancer: Results of CALGB 9781." J Clin Oncol 24, no. 18_suppl (June 20, 2006): 4012-. Link to Item
  - Venook, A, Niedzwiecki, D, Hollis, D, Sutherland, S, Goldberg, R, Alberts, S, Benson, A, Wade, J, Schilsky, R, and Mayer, R. "Phase III study of irinotecan/5FU/LV (FOLFIRI) or oxaliplatin/5FU/LV (FOLFOX) ± cetuximab for patients (pts) with untreated metastatic adenocarcinoma of the colon or rectum (MCRC): CALGB 80203 preliminary results." J Clin Oncol 24, no. 18_suppl (June 20, 2006): 3509-. Link to Item
  - Cancer and Leukemia Group B 89901, , Ryan, DP, Niedzwiecki, D, Hollis, D, Mediema, BE, Wadler, S, Tepper, JE, Goldberg, RM, and Mayer, RJ. "Phase I/II study of preoperative oxaliplatin, fluorouracil, and external-beam radiation therapy in patients with locally advanced rectal cancer: Cancer and Leukemia Group B 89901." J Clin Oncol 24, no. 16 (June 1, 2006): 2557-2562. Full Text Link to Item
  - Vredenburgh, JJ, Madan, B, Coniglio, D, Ross, M, Broadwater, G, Niedzwiecki, D, Edwards, J, Marks, L, Vandemark, R, McDonald, C, Affronti, ML, and Peters, WP. "A randomized phase III comparative trial of immediate consolidation with high-dose chemotherapy and autologous peripheral blood progenitor cell support compared to observation with delayed consolidation in women with metastatic breast cancer and only bone metastases following intensive induction chemotherapy." Bone Marrow Transplant 37, no. 11 (June 2006): 1009-1015. Full Text Link to Item
  - Thompson, WM, Foster, WL, Paulson, EK, Niedzwiecki, D, Low, VH, Fulford, LB, Broomer, BW, Sanders, L, and Rockey, DC. "Causes of errors in polyp detection at air-contrast barium enema examination." Radiology 239, no. 1 (April 2006): 139-148. (Academic Article)
  - Kemeny, NE, Niedzwiecki, D, Hollis, DR, Lenz, H-J, Warren, RS, Naughton, MJ, Weeks, JC, Sigurdson, ER, Herndon, JE, Zhang, C, and Mayer, RJ. "Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer: a randomized trial of efficacy, quality of life, and molecular markers (CALGB 9481)." J Clin Oncol 24, no. 9 (March 20, 2006): 1395-1403. Full Text Link to Item
  - Redston, M, Compton, CC, Miedema, BW, Niedzwiecki, D, Dowell, JM, Jewell, SD, Fleshman, JM, Bem, J, Mayer, RJ, Bertagnolli, MM, and Leukemia Group B Trial 80001, . "Analysis of micrometastatic disease in sentinel lymph nodes from resectable colon cancer: results of Cancer and Leukemia Group B Trial 80001." J Clin Oncol 24, no. 6 (February 20, 2006): 878-883. Full Text Link to Item
  - Blum, KA, Johnson, JL, Niedzwiecki, D, Piro, LD, Saven, A, Peterson, BA, Byrd, JC, and Cheson, BD. "Prolonged follow-up after initial therapy with 2-chlorodeoxyadenosine in patients with indolent non-Hodgkin lymphoma: Results of cancer and leukemia group B study 9153." Cancer 107, no. 12 (2006): 2817-2825. Full Text
  - Franklin, J, Pluetschow, A, Paus, M, Specht, L, Anselmo, A-P, Aviles, A, Biti, G, Bogatyreva, T, Bonadonna, G, Brillant, C, Cavalieri, E, Diehl, V, Eghbali, H, Fermé, C, Henry-Amar, M, Hoppe, R, Howard, S, Meyer, R, Niedzwiecki, D, Pavlovsky, S, Radford, J, Raemaekers, J, Ryder, D, Schiller, P, Shakhtarina, S, Valagussa, P, Wilimas, J, and Yahalom, J. "Second malignancy risk associated with treatment of Hodgkin's lymphoma: Meta-analysis of the randomised trials." Annals of Oncology 17, no. 12 (2006): 1749-1760. Full Text
  - Goldberg, RM, Niedzwiecki, D, Bertagnolli, M, Blackstock, AW, Tepper, JE, and Mayer, RJ. "Cancer and Leukemia Group B Gastrointestinal Cancer Committee." Clinical Cancer Research 12, no. 11 II (2006): 3589s-3595s. Full Text
  - Krown, SE, Niedzwiecki, D, Hwu, W-J, Hodgson, L, Houghton, AN, and Haluska, FG. "Phase II study of temozolomide and thalidomide in patients with metastatic melanoma in the brain: High rate of thromboembolic events (CALGB 500102)." Cancer 107, no. 8 (2006): 1883-1890. Full Text
  - Meyerhardt, JA, Heseltine, D, Niedzwiecki, D, Hollis, D, Saltz, LB, Mayer, RJ, Thomas, J, Nelson, H, Whittom, R, Hantel, A, Schilsky, RL, and Fuchs, CS. "Impact of physical activity on cancer recurrence and survival in patients with stage III colon cancer: Findings from CALGB 89803." Journal of Clinical Oncology 24, no. 22 (2006): 3535-3541. Full Text
  - Roberts, JD, Niedzwiecki, D, Carson, WE, Chapman, PB, Gajewski, TF, Ernstoff, MS, Hodi, FS, Shea, C, Leong, SP, Johnson, J, Zhang, D, Houghton, A, Haluska, FG, and Cancer and Leukemia Group B, . "Phase 2 study of the g209-2M melanoma peptide vaccine and low-dose interleukin-2 in advanced melanoma: Cancer and Leukemia Group B 509901." J Immunother 29, no. 1 (January 2006): 95-101. Link to Item
  - Smith, SM, Johnson, JL, Niedzwiecki, D, Eder, JP, Canellos, G, Cheson, BD, and Bartlett, NL. "Sequential doxorubicin and topotecan in relapsed/refractory aggressive non-Hodgkin's lymphoma: Results of CALGB 59906." Leukemia and Lymphoma 47, no. 8 (2006): 1511-1517. Full Text
  - Thompson, WM, Foster, WL, Paulson, EK, Niedzwiecki, D, Low, VHS, Fulford, LB, Broomer, BW, Sanders, L, and Rockey, DC. "Comparison of radiologists and technologists in the performance of air-contrast barium enemas." American Journal of Roentgenology 187, no. 3 (2006): 706-709. Full Text
  - Venook, AP, Blanke, CD, Niedzwiecki, D, Lenz, H-J, Taylor, JR, Hollis, DR, Sutherland, S, and Goldberg, RM. "Cancer and Leukemia Group B/Southwest Oncology Group trial 80405: a phase III trial of chemotherapy and biologics for patients with untreated advanced colorectal adenocarcinoma." Clin Colorectal Cancer 5, no. 4 (November 2005): 292-294. Link to Item
  - Rizzieri, DA, Wadleigh, M, Wikstrand, CJ, Mann, KP, Sen, F, Peterson, BL, Niedzwiecki, D, Proia, AD, and Bigner, DD. "Tenascin and microvessel stromal changes in patients with non-Hodgkin's lymphoma are isolated to the sites of disease and vary in correlation to disease activity." Leuk Lymphoma 46, no. 10 (October 2005): 1455-1462. Full Text Link to Item
  - Storms, RW, Green, PD, Safford, KM, Niedzwiecki, D, Cogle, CR, Colvin, OM, Chao, NJ, Rice, HE, and Smith, CA. "Distinct hematopoietic progenitor compartments are delineated by the expression of aldehyde dehydrogenase and CD34." Blood 106, no. 1 (July 1, 2005): 95-102. Full Text Link to Item
  - Fuchs, C, Meyerhardt, JA, Heseltine, DL, Niedzwiecki, D, Hollis, D, Chan, AT, Saltz, LB, Schilsky, RL, and Mayer, RJ. "Influence of regular aspirin use on survival for patients with stage III colon cancer: Findings from Intergroup trial CALGB 89803." Journal of clinical oncology : official journal of the American Society of Clinical Oncology 23, no. 16_suppl (June 2005): 3530-.
  - Meyerhardt, JA, Heseltine, D, Niedzwiecki, D, Hollis, D, Saltz, LB, Mayer, RJ, Schilsky, RL, and Fuchs, CS. "The impact of physical activity on patients with stage III colon cancer: Findings from Intergroup trial CALGB 89803." Journal of clinical oncology : official journal of the American Society of Clinical Oncology 23, no. 16_suppl (June 2005): 3534-.
  - Wilson, WH, Porcu, P, Hurd, D, Martin, SE, Czuczman, M, Niedzwiecki, D, Saint Louis, JD, Johnson, JL, Cheson, B, Canellos, GP, and Zelenetz, AD. "Phase II study of dose-adjusted EPOCH-R in untreated de novo CD20+ diffuse large B-cell lymphoma (DLBCL)-CALGB 50103." Journal of clinical oncology : official journal of the American Society of Clinical Oncology 23, no. 16_suppl (June 2005): 6530-.
  - Morse, MA, Clay, TM, Hobeika, AC, Osada, T, Khan, S, Chui, S, Niedzwiecki, D, Panicali, D, Schlom, J, and Lyerly, HK. "Phase I study of immunization with dendritic cells modified with fowlpox encoding carcinoembryonic antigen and costimulatory molecules." Clin Cancer Res 11, no. 8 (April 15, 2005): 3017-3024. Full Text Link to Item
  - Su, Z, Dannull, J, Yang, BK, Dahm, P, Coleman, D, Yancey, D, Sichi, S, Niedzwiecki, D, Boczkowski, D, Gilboa, E, and Vieweg, J. "Telomerase mRNA-transfected dendritic cells stimulate antigen-specific CD8+ and CD4+ T cell responses in patients with metastatic prostate cancer." J Immunol 174, no. 6 (March 15, 2005): 3798-3807. Link to Item
  - Szabolcs, P, Park, K, Marti, L, Reese, M, Lee, Y, DeOliveira, D, Sanders, L, and Niedzwiecki, D. "The impact of immune reconstitution on the development of opportunistic infections (OI) after unrelated umbilical cord blood transplantation (UUCBT). A multivariate analysis of host, graft, and day+50 immune profile." BONE MARROW TRANSPLANTATION 35 (March 2005): S93-S93. Link to Item
  - Hobeika, AC, Morse, MA, Osada, T, Ghanayem, M, Niedzwiecki, D, Barrier, R, Lyerly, HK, and Clay, TM. "Enumerating antigen-specific T-cell responses in peripheral blood: a comparison of peptide MHC Tetramer, ELISpot, and intracellular cytokine analysis." J Immunother 28, no. 1 (January 2005): 63-72. Link to Item
  - Rockey, DC, Paulson, E, Niedzwiecki, D, Davis, W, Bosworth, HB, Sanders, L, Yee, J, Henderson, J, Hatten, P, Burdick, S, Sanyal, A, Rubin, DT, Sterling, M, Akerkar, G, Bhutani, MS, Binmoeller, K, Garvie, J, Bini, EJ, McQuaid, K, Foster, WL, Thompson, WM, Dachman, A, and Halvorsen, R. "Analysis of air contrast barium enema, computed tomographic colonography, and colonoscopy: prospective comparison." Lancet (London, England) 365, no. 9456 (January 2005): 305-311. Full Text
  - Goel, A, Arnold, CN, Tassone, P, Chang, DK, Niedzwiecki, D, Dowell, JM, Wasserman, L, Compton, C, Mayer, RJ, Bertagnolli, MM, and Boland, CR. "Epigenetic inactivation of RUNX3 in microsatellite unstable sporadic colon cancers." Int J Cancer 112, no. 5 (December 10, 2004): 754-759. Full Text Link to Item
  - Arnold, CN, Goel, A, Niedzwiecki, D, Dowell, JM, Wasserman, L, Compton, C, Mayer, RJ, Bertagnolli, MM, and Boland, CR. "APC promoter hypermethylation contributes to the loss of APC expression in colorectal cancers with allelic loss on 5q." Cancer Biol Ther 3, no. 10 (October 2004): 960-964. Link to Item
  - Bertagnolli, M, Miedema, B, Redston, M, Dowell, J, Niedzwiecki, D, Fleshman, J, Bem, J, Mayer, R, Zinner, M, and Compton, C. "Sentinel node staging of resectable colon cancer: results of a multicenter study." Ann Surg 240, no. 4 (October 2004): 624-628. Link to Item
  - Bertagnolli, MM, Redston, M, Miedema, B, Dowell, J, Niedzwiecki, D, Mayer, R, Fleshman, J, Bem, J, and Compton, C. "Sentinel node staging of resectable colon cancer: Results of CALGB 80001." Journal of clinical oncology : official journal of the American Society of Clinical Oncology 22, no. 14_suppl (July 2004): 3506-.
  - Colacchio, TA, Niedzwiecki, D, Compton, C, Warren, R, Benson, AI, Goldberg, R, Kerr, D, Fields, A, Hollis, D, and Mayer, R. "Phase III trial of adjuvant immunotherapy with MOAb 17-1A following resection for stage II adenocarcinoma of the colon (CALGB 9581)." Journal of clinical oncology : official journal of the American Society of Clinical Oncology 22, no. 14_suppl (July 2004): 3522-.
  - Kulke, MH, Niedzwiecki, D, Tempero, MA, Hollis, DR, and Mayer, RJ. "A randomized phase II study of gemcitabine/cisplatin, gemcitabine fixed dose rate infusion, gemcitabine/docetaxel, or gemcitabine/irinotecan in patients with metastatic pancreatic cancer (CALGB 89904)." Journal of clinical oncology : official journal of the American Society of Clinical Oncology 22, no. 14_suppl (July 2004): 4011-.
  - Ryan, DP, Niedzwiecki, D, Hollis, D, Miedema, BE, Wadler, S, Tepper, JE, and Mayer, RJ. "A phase I/II study of preoperative oxaliplatin (O), 5-fluorouracil (5-FU), and external beam radiation therapy (XRT) in locally advanced rectal cancer: CALGB 89901." Journal of clinical oncology : official journal of the American Society of Clinical Oncology 22, no. 14_suppl (July 2004): 3560-.
  - Saltz, LB, Niedzwiecki, D, Hollis, D, Goldberg, RM, Hantel, A, Thomas, JP, Fields, AL, Carver, G, and Mayer, RJ. "Irinotecan plus fluorouracil/leucovorin (IFL) versus fluorouracil/leucovorin alone (FL) in stage III colon cancer (intergroup trial CALGB C89803)." Journal of clinical oncology : official journal of the American Society of Clinical Oncology 22, no. 14_suppl (July 2004): 3500-.
  - Rizzieri, DA, Sand, GJ, McGaughey, D, Moore, JO, DeCastro, C, Chao, NJ, Vredenburgh, JJ, Gasparetto, C, Long, GD, Anderson, E, Foster, T, Toaso, B, Adams, D, Niedzwiecki, D, and Gockerman, JP. "Low-dose weekly paclitaxel for recurrent or refractory aggressive non-Hodgkin lymphoma." Cancer 100, no. 11 (June 1, 2004): 2408-2414. Full Text Link to Item
  - Goel, A, Arnold, CN, Niedzwiecki, D, Carethers, JM, Dowell, JM, Wasserman, L, Compton, C, Mayer, RJ, Bertagnolli, MM, and Boland, CR. "Frequent inactivation of PTEN by promoter hypermethylation in microsatellite instability-high sporadic colorectal cancers." Cancer Res 64, no. 9 (May 1, 2004): 3014-3021. Link to Item
  - Canellos, GP, Duggan, D, Johnson, J, and Niedzwiecki, D. "How important is bleomycin in the adriamycin + bleomycin + vinblastine + dacarbazine regimen?." J Clin Oncol 22, no. 8 (April 15, 2004): 1532-1533. (Letter) Full Text Link to Item
  - Rizzieri, DA, Johnson, JL, Niedzwiecki, D, Lee, EJ, Vardiman, JW, Powell, BL, Barcos, M, Bloomfield, CD, Schiffer, CA, Peterson, BA, Canellos, GP, and Larson, RA. "Intensive chemotherapy with and without cranial radiation for Burkitt leukemia and lymphoma: final results of Cancer and Leukemia Group B Study 9251." Cancer 100, no. 7 (April 1, 2004): 1438-1448. Full Text Link to Item
  - Meyerhardt, JA, Tepper, JE, Niedzwiecki, D, Hollis, DR, McCollum, AD, Brady, D, O'Connell, MJ, Mayer, RJ, Cummings, B, Willett, C, Macdonald, JS, Benson, AB, and Fuchs, CS. "Impact of body mass index on outcomes and treatment-related toxicity in patients with stage II and III rectal cancer: findings from Intergroup Trial 0114." J Clin Oncol 22, no. 4 (February 15, 2004): 648-657. Full Text Link to Item
  - Arnold, CN, Goel, A, Compton, C, Marcus, V, Niedzwiecki, D, Dowell, JM, Wasserman, L, Inoue, T, Mayer, RJ, Bertagnolli, MM, and Boland, CR. "Evaluation of microsatellite instability, hMLH1 expression and hMLH1 promoter hypermethylation in defining the MSI phenotype of colorectal cancer." Cancer Biol Ther 3, no. 1 (January 2004): 73-78. Link to Item
  - Meyerhardt, JA, Tepper, JE, Niedzwiecki, D, Hollis, DR, Schrag, D, Ayanian, JZ, O'Connell, MJ, Weeks, JC, Mayer, RJ, Willett, CG, MacDonald, JS, Benson, AB, and Fuchs, CS. "Impact of hospital procedure volume on surgical operation and long-term outcomes in high-risk curatively resected rectal cancer: findings from the Intergroup 0114 Study." J Clin Oncol 22, no. 1 (January 1, 2004): 166-174. Full Text Link to Item
  - Long, GD, Laughlin, M, Madan, B, Kurtzberg, J, Gasparetto, C, Morris, A, Rizzieri, D, Smith, C, Vredenburgh, J, Halperin, EC, Broadwater, G, Niedzwiecki, D, and Chao, NJ. "Unrelated umbilical cord blood transplantation in adult patients." Biol Blood Marrow Transplant 9, no. 12 (December 2003): 772-780. Full Text Link to Item
  - Tepper, JE, O'Connell, M, Hollis, D, Niedzwiecki, D, Cooke, E, Mayer, RJ, and Intergroup Study 0114, . "Analysis of surgical salvage after failure of primary therapy in rectal cancer: results from Intergroup Study 0114." J Clin Oncol 21, no. 19 (October 1, 2003): 3623-3628. Full Text Link to Item
  - Su, Z, Dannull, J, Heiser, A, Yancey, D, Pruitt, S, Madden, J, Coleman, D, Niedzwiecki, D, Gilboa, E, and Vieweg, J. "Immunological and clinical responses in metastatic renal cancer patients vaccinated with tumor RNA-transfected dendritic cells." Cancer Res 63, no. 9 (May 1, 2003): 2127-2133. Link to Item
  - Goel, A, Arnold, CN, Niedzwiecki, D, Chang, DK, Ricciardiello, L, Carethers, JM, Dowell, JM, Wasserman, L, Compton, C, Mayer, RJ, Bertagnolli, MM, and Boland, CR. "Characterization of sporadic colon cancer by patterns of genomic instability." Cancer Res 63, no. 7 (April 1, 2003): 1608-1614. Link to Item
  - Canellos, GP, and Niedzwiecki, D. "Long-term follow-up of Hodgkin's disease trial." N Engl J Med 346, no. 18 (May 2, 2002): 1417-1418. (Letter) Full Text Link to Item
  - Tepper, JE, O'Connell, M, Niedzwiecki, D, Hollis, DR, Benson, AB, Cummings, B, Gunderson, LL, Macdonald, JS, Martenson, JA, and Mayer, RJ. "Adjuvant therapy in rectal cancer: analysis of stage, sex, and local control--final report of intergroup 0114." J Clin Oncol 20, no. 7 (April 1, 2002): 1744-1750. Full Text Link to Item
  - Long, GD, Laughlin, M, Madan, B, Kurtzberg, J, Rubinstein, P, Gasparetto, C, Morris, A, Rizzieri, D, Smith, C, Vredenburgh, J, Halperin, EC, Broadwater, G, Niedzwiecki, D, and Chao, NJ. "Transplantation of unrelated umbilical cord blood in adult patients." LEUKEMIA 16, no. 3 (March 2002): 411-411. Link to Item
  - Heiser, A, Coleman, D, Dannull, J, Yancey, D, Maurice, MA, Lallas, CD, Dahm, P, Niedzwiecki, D, Gilboa, E, and Vieweg, J. "Autologous dendritic cells transfected with prostate-specific antigen RNA stimulate CTL responses against metastatic prostate tumors." J Clin Invest 109, no. 3 (February 2002): 409-417. Full Text Link to Item
  - Rizzieri, DA, Akabani, G, Coleman, RE, Zalutsky, MR, Niedzwiecki, D, Payne, N, Wikstrand, C, and Bigner, DD. "Radiolabeled anti-tenascin antibody for refractory non-Hodgkins lymphoma (NHL)." BLOOD 98, no. 11 (November 16, 2001): 247B-247B. Link to Item
  - Rizzieri, DA, DeCastro, C, Gockerman, JP, Niedzwiecki, D, Vredenburgh, JJ, Gasparetto, C, Long, G, Payne, N, Ibom, V, Chao, NJ, and Moore, JO. "Low dose, weekly, paclitaxel as salvage therapy for non-Hodgkins lymphoma (NHL)." BLOOD 98, no. 11 (November 16, 2001): 246B-246B. Link to Item
  - Rizzieri, DA, Gockerman, JP, Moore, JO, DeCastro, C, Long, GD, Vredenburgh, JJ, Niedzwiecki, D, Edwards, J, Prosnitz, L, Gasparetto, C, Morris, A, Lassiter, M, Davis, P, and Chao, NJ. "Dose dense, high intensity therapy for mantle cell lymphoma." BLOOD 98, no. 11 (November 16, 2001): 681A-682A. Link to Item
  - Rizzieri, DA, Long, GD, Vredenburgh, JJ, Gasparetto, C, Morris, A, Lassiter, M, Loftis, J, Davis, P, McDonald, C, Stenzel, T, Niedzwiecki, D, and Chao, NJ. "Non-myeloablative allogeneic transplantation using T depleted matched sibling peripheral blood stem cells." BLOOD 98, no. 11 (November 16, 2001): 420A-421A. Link to Item
  - Rizzieri, DA, Long, GD, Vredenburgh, JJ, Gasparetto, C, Morris, A, Lassiter, M, Loftis, J, Davis, P, McDonald, C, Stenzel, T, Niedzwiecki, D, and Chao, NJ. "Non-myeloablative transplantation using CAMPATH 1H for T depletion of mismatched, related donor peripheral blood stem cells." BLOOD 98, no. 11 (November 16, 2001): 669A-669A. Link to Item
  - Rizzieri, DA, Long, GD, Vredenburgh, JJ, Gasparetto, C, Morris, A, Niedzwiecki, D, Lassiter, M, Loftis, J, Davis, P, McDonald, C, Stenzel, T, Waters-Pick, B, Kurtzberg, J, and Chao, NJ. "Durable engraftment of mismatched unrelated cord blood following a non-myeloablative preparative regimen for adults." BLOOD 98, no. 11 (November 16, 2001): 185A-185A. Link to Item
  - Szabolcs, P, Park, KD, Reese, M, Marti, L, Broadwater, G, Niedzwiecki, D, DeOliveira, D, and Kurtzberg, J. "Reconstitution of T cell and dendritic cell immunity 50 days post unrelated cord blood transplant predicts the incidence of opportunistic infections and acute GVHD in children." BLOOD 98, no. 11 (November 16, 2001): 204A-204A. Link to Item
  - Wadleigh, M, Niedzwiecki, D, Davis, P, Payne, N, Sen, F, Mann, KP, Proia, A, Hollis, D, and Rizzieri, DA. "Increased microvessel density in non-Hodgkin's lymphoma (NHL) is localized to the site of disease changes in accordance with disease response." BLOOD 98, no. 11 (November 16, 2001): 236B-236B. Link to Item
  - Lichtman, SM, Petroni, G, Schilsky, RL, Johnson, JL, Perri, RT, Niedzwiecki, D, Sklar, J, Barcos, M, and Peterson, BA. "High dose cyclophosphamide plus recombinant human granulocyte-colony stimulating factor (rhG-CSF) in the treatment of follicular, low grade non-Hodgkin's lymphoma: CALGB 9150." Leuk Lymphoma 42, no. 6 (November 2001): 1255-1264. Full Text Link to Item
  - Bortell, R, Moss, J, McKenna, RC, Rigby, MR, Niedzwiecki, D, Stevens, LA, Patton, WA, Mordes, JP, Greiner, DL, and Rossini, AA. "Nicotinamide adenine dinucleotide (NAD) and its metabolites inhibit T lymphocyte proliferation: role of cell surface NAD glycohydrolase and pyrophosphatase activities." J Immunol 167, no. 4 (August 15, 2001): 2049-2059. Link to Item
  - Sargent, DJ, Niedzwiecki, D, O'Connell, MJ, and Schilsky, RL. "Recommendation for caution with irinotecan, fluorouracil, and leucovorin for colorectal cancer." N Engl J Med 345, no. 2 (July 12, 2001): 144-145. (Letter) Full Text Link to Item
  - Arnold, CN, Goel, A, Carethers, JM, Wasserman, L, Compton, C, Niedzwiecki, D, Mayer, RJ, Bertagnolli, MM, and Boland, CR. "A panel of mono- and dinucleotide microsatellite markers is required for reliable determination of the MSI status in colorectal cancer." GASTROENTEROLOGY 120, no. 5 (April 2001): A599-A599. Link to Item
  - Arnold, CN, Goel, A, Chang, DK, Wasserman, L, Compton, C, Niedzwiecki, D, Mayer, RJ, Bertagnolli, MM, and Boland, CR. "Microsatellite high (MSI-H) tumors are not associated with LOH at the APC locus compared to microsatellite-low/stable (MSI-L/MSS) tumors." GASTROENTEROLOGY 120, no. 5 (April 2001): A296-A296. Link to Item
  - Goel, A, Arnold, CN, Chang, DK, Ricciardiello, L, Chauhan, DP, Carethers, JM, Wasserman, L, Compton, C, Niedzwiecki, D, Mayer, RJ, Bertagnolli, MM, and Boland, CR. "Chromosomal vs microsatellite instability in colorectal cancers: Evidence for previously unrecognized pathways." GASTROENTEROLOGY 120, no. 5 (April 2001): A163-A163. Link to Item
  - Goel, A, Arnold, CN, Ricciardiello, L, Chang, DK, Wasserman, L, Compton, C, Niedzwiecki, D, Mayer, RJ, Bertagnolli, MM, and Boland, R. "Somatic frameshift mutations in MBD4 (MED1) are not exclusively associated with microsatellite high (MSI-H) colorectal tumors." GASTROENTEROLOGY 120, no. 5 (April 2001): A293-A293. Link to Item
  - Meropol, NJ, Niedzwiecki, D, Hollis, D, Schilsky, RL, Mayer, RJ, and Cancer and Leukemia Group B, . "Phase II study of oral eniluracil, 5-fluorouracil, and leucovorin in patients with advanced colorectal carcinoma." Cancer 91, no. 7 (April 1, 2001): 1256-1263. Link to Item
  - Meropol, NJ, Niedzwiecki, D, Hollis, D, Schilsky, RL, and Mayer, RJ. "Phase II study of oral eniluracil, 5-fluorouracil, and leucovorin in patients with advanced colorectal carcinoma." Cancer 91, no. 7 (April 1, 2001): 1256-1263. Full Text
  - Tepper, JE, O'Connell, MJ, Niedzwiecki, D, Hollis, D, Compton, C, Benson, AB, Cummings, B, Gunderson, L, Macdonald, JS, and Mayer, RJ. "Impact of number of nodes retrieved on outcome in patients with rectal cancer." J Clin Oncol 19, no. 1 (January 1, 2001): 157-163. Full Text Link to Item
  - Morse, MA, Nair, S, Fernandez-Casal, M, Deng, Y, St Peter, M, Williams, R, Hobeika, A, Mosca, P, Clay, T, Cumming, RI, Fisher, E, Clavien, P, Proia, AD, Niedzwiecki, D, Caron, D, and Lyerly, HK. "Preoperative mobilization of circulating dendritic cells by Flt3 ligand administration to patients with metastatic colon cancer." J Clin Oncol 18, no. 23 (December 1, 2000): 3883-3893. Full Text Link to Item
  - Szabolcs, P, Park, KD, Reese, M, Niedzwiecki, D, Chao, NJ, and Kurtzberg, J. "Predictive value of day+50 immune reconstitution on the incidence of opportunistic infections and acute GVHD following unrelated cord blood transplants in children." BLOOD 96, no. 11 (November 16, 2000): 789A-789A. Link to Item
  - Lichtman, SM, Niedzwiecki, D, Barcos, M, Carlisle, TL, Cooper, MR, Johnson, JL, and Peterson, BA. "Phase II study of infusional chemotherapy with doxorubicin, vincristine and etoposide plus cyclophosphamide and prednisone (I-CHOPE) in resistant diffuse aggressive non-Hodgkin's lymphoma: CALGB 9255. Cancer and Leukemia Group B." Ann Oncol 11, no. 9 (September 2000): 1141-1146. Link to Item
  - Rizzieri, DA, Wikstrand, CJ, Mann, KP, Sen, F, Proia, AD, Niedzwiecki, D, Bigner, DD, and Vredenburgh, J. "Markers of angiogenesis, factor VIII and tenascin, correlate with disease activity in patients with Non-Hodgkin's Lymphoma." BLOOD 94, no. 10 (November 15, 1999): 253B-253B. Link to Item
  - Stason, WB, Schmid, CH, Niedzwiecki, D, Whiting, GW, Caubet, J-F, Cory, D, Luo, D, Ross, SD, and Chalmers, TC. "Safety of nifedipine in angina pectoris: A meta-analysis." Hypertension 33, no. 1 I (1999): 24-31.
  - Stason, WB, Schmid, CH, Niedzwiecki, D, Whiting, GW, Caubet, J-F, Luo, D, Ross, SD, and Chalmers, TC. "Erratum: Safety of nifedipine in patients with hypertension: A meta- analysis (Hypertension 30 (7-14))." Hypertension 34, no. 3 (1999): 531--.
  - Stason, WB, Schmid, CH, Niedzwiecki, D, Whiting, GW, Caubet, JF, Cory, D, Luo, D, Ross, SD, and Chalmers, TC. "Safety of nifedipine in angina pectoris: a meta-analysis." Hypertension 33, no. 1 (January 1999): 24-31. Link to Item
  - Jiang, J, McMurtry, J, Niedzwiecki, D, and Goldman, SA. "Insulin-like growth factor-1 is a radial cell-associated neurotrophin that promotes neuronal recruitment from the adult songbird edpendyma/subependyma." J Neurobiol 36, no. 1 (July 1998): 1-15. Link to Item
  - Stason, WB, Schmid, CH, Niedzwiecki, D, Whiting, GW, Caubet, JF, Luo, D, Ross, SD, and Chalmers, TC. "Safety of nifedipine in patients with hypertension: a meta-analysis." Hypertension 30, no. 1 Pt 1 (July 1997): 7-14. Link to Item
  - Stason, WB, Schmid, CH, Niedzwiecki, D, Whiting, GW, Luo, D, Ross, SD, and Chalmers, TC. "Safety of nifedipine in patients with hypertension: A meta-analysis." Hypertension 30, no. 1 (1997): 7-14.
  - Goldman, SA, Zukhar, A, Barami, K, Mikawa, T, and Niedzwiecki, D. "Ependymal/subependymal zone cells of postnatal and adult songbird brain generate both neurons and nonneuronal siblings in vitro and in vivo." Journal of Neurobiology 30, no. 4 (August 1, 1996): 505-520. Full Text
  - Goldman, SA, Zukhar, A, Barami, K, Mikawa, T, and Niedzwiecki, D. "Ependymal/subependymal zone cells of postnatal and adult songbird brain generate both neurons and nonneuronal siblings in vitro and in vivo." J Neurobiol 30, no. 4 (August 1996): 505-520. Full Text Link to Item
  - Kelsen, DP, Portenoy, RK, Thaler, HT, Niedzwiecki, D, Passik, SD, Tao, Y, Banks, W, Brennan, MF, and Foley, KM. "Pain and depression in patients with newly diagnosed pancreas cancer." J Clin Oncol 13, no. 3 (March 1995): 748-755. Full Text Link to Item
  - Albino, AP, Jaehne, J, Altorki, N, Blundell, M, Urmacher, C, Lauwers, G, Niedzwiecki, D, and Kelsen, DP. "Amplification of HER-2/neu gene in human gastric adenocarcinomas: correlation with primary site." Eur J Surg Oncol 21, no. 1 (February 1995): 56-60. Link to Item
  - Doukas, J, Mordes, JP, Swymer, C, Niedzwiecki, D, Mason, R, Rozing, J, Rossini, AA, and Greiner, DL. "Thymic epithelial defects and predisposition to autoimmune disease in BB rats." Am J Pathol 145, no. 6 (December 1994): 1517-1525. Link to Item
  - Rivoire, ML, Yoshida, K, Voiglio, EJ, Divgi, CR, Niedzwiecki, D, Chapman, D, Cohen, AM, and Sigurdson, ER. "Intraportal injection of monoclonal antibody in nude mice bearing hepatic metastases." J Surg Oncol 54, no. 2 (October 1993): 71-77. Link to Item
  - Saltz, L, Sirott, M, Young, C, Tong, W, Niedzwiecki, D, Tzy-Jyun, Y, Tao, Y, Trochanowski, B, Wright, P, and Barbosa, K. "Phase I clinical and pharmacology study of topotecan given daily for 5 consecutive days to patients with advanced solid tumors, with attempt at dose intensification using recombinant granulocyte colony-stimulating factor." J Natl Cancer Inst 85, no. 18 (September 15, 1993): 1499-1507. Link to Item
  - Göker, E, Lin, JT, Trippett, T, Elisseyeff, Y, Tong, WP, Niedzwiecki, D, Tan, C, Steinherz, P, Schweitzer, BI, and Bertino, JR. "Decreased polyglutamylation of methotrexate in acute lymphoblastic leukemia blasts in adults compared to children with this disease." Leukemia 7, no. 7 (July 1993): 1000-1004. Link to Item
  - Saltz, L, Trochanowski, B, Buckley, M, Heffernan, B, Niedzwiecki, D, Tao, Y, and Kelsen, D. "Octreotide as an antineoplastic agent in the treatment of functional and nonfunctional neuroendocrine tumors." Cancer 72, no. 1 (July 1, 1993): 244-248. Link to Item
  - Kemeny, N, Conti, JA, Sigurdson, E, Cohen, A, Seiter, K, Lincer, R, Niedzwiecki, D, Botet, J, Chapman, D, and Costa, P. "A pilot study of hepatic artery floxuridine combined with systemic 5-fluorouracil and leucovorin. A potential adjuvant program after resection of colorectal hepatic metastases." Cancer 71, no. 6 (March 15, 1993): 1964-1971. Link to Item
  - Atiq, OT, Kelsen, DP, Shiu, MH, Saltz, L, Tong, W, Niedzwiecki, D, Trochanowski, B, Lin, S, Toomasi, F, and Brennan, M. "Phase II trial of postoperative adjuvant intraperitoneal cisplatin and fluorouracil and systemic fluorouracil chemotherapy in patients with resected gastric cancer." J Clin Oncol 11, no. 3 (March 1993): 425-433. Full Text Link to Item
  - Kemeny, N, Cohen, A, Seiter, K, Conti, JA, Sigurdson, ER, Tao, Y, Niedzwiecki, D, Botet, J, and Budd, A. "Randomized trial of hepatic arterial floxuridine, mitomycin, and carmustine versus floxuridine alone in previously treated patients with liver metastases from colorectal cancer." J Clin Oncol 11, no. 2 (February 1993): 330-335. Full Text Link to Item
  - Kemeny, N, Conti, JA, Sigurdson, E, Cohen, A, Seiter, K, Lincer, R, Niedzwiecki, D, Botet, J, Chapman, D, Costa, P, and Budd, A. "A pilot study of hepatic artery floxuridine combined with systemic 5‐fluorouracil and leucovorin. A potential adjuvant program after resection of colorectal hepatic metastases." Cancer 71, no. 6 (January 1, 1993): 1964-1971. Full Text
  - Saltz, L, Trochanowski, B, Buckley, M, Heffernan, B, Niedzwiecki, D, Tao, Y, and Kelsen, D. "Octreotide as an antineoplastic agent in the treatment of functional and nonfunctional neuroendocrine tumors." Cancer 72, no. 1 (January 1, 1993): 244-248. Full Text
  - Niedt, GW, Myskowski, PL, Urmacher, C, Niedzwiecki, D, Chapman, D, Krown, SE, and Safai, B. "Histologic predictors of survival in acquired immunodeficiency syndrome-associated Kaposi's sarcoma." Hum Pathol 23, no. 12 (December 1992): 1419-1426. Link to Item
  - Li, WW, Lin, JT, Schweitzer, BI, Tong, WP, Niedzwiecki, D, and Bertino, JR. "Intrinsic resistance to methotrexate in human soft tissue sarcoma cell lines." Cancer Res 52, no. 14 (July 15, 1992): 3908-3913. Link to Item
  - Goldman, SA, Zaremba, A, and Niedzwiecki, D. "In vitro neurogenesis by neuronal precursor cells derived from the adult songbird brain." J Neurosci 12, no. 7 (July 1992): 2532-2541. Link to Item
  - Rusch, VW, Niedzwiecki, D, Tao, Y, Menendez-Botet, C, Dnistrian, A, Kelsen, D, Saltz, L, and Markman, M. "Intrapleural cisplatin and mitomycin for malignant mesothelioma following pleurectomy: pharmacokinetic studies." J Clin Oncol 10, no. 6 (June 1992): 1001-1006. Full Text Link to Item
  - Kemeny, N, Conti, JA, Seiter, K, Niedzwiecki, D, Botet, J, Martin, D, Costa, P, Wiseberg, J, and McCulloch, W. "Biochemical modulation of bolus fluorouracil by PALA in patients with advanced colorectal cancer." J Clin Oncol 10, no. 5 (May 1992): 747-752. Full Text Link to Item
  - Kelsen, D, Atiq, OT, Saltz, L, Niedzwiecki, D, Ginn, D, Chapman, D, Heelan, R, Lightdale, C, Vinciguerra, V, and Brennan, M. "FAMTX versus etoposide, doxorubicin, and cisplatin: a random assignment trial in gastric cancer." J Clin Oncol 10, no. 4 (April 1992): 541-548. Full Text Link to Item
  - Kostakoglu, L, Yeh, SD, Portlock, C, Heelan, R, Yao, TJ, Niedzwiecki, D, and Larson, SM. "Validation of gallium-67-citrate single-photon emission computed tomography in biopsy-confirmed residual Hodgkin's disease in the mediastinum." J Nucl Med 33, no. 3 (March 1992): 345-350. Link to Item
  - Atiq, OT, Kemeny, N, Niedzwiecki, D, and Botet, J. "Treatment of unresectable primary liver cancer with intrahepatic fluorodeoxyuridine and mitomycin C through an implantable pump." Cancer 69, no. 4 (February 15, 1992): 920-924. Link to Item
  - Sutanto-Ward, E, Sigurdson, ER, Tremiterra, S, Lincer, R, Chapman, D, and Niedzwiecki, D. "Adjuvant chemotherapy for colorectal hepatic metastases: role of route of administration and timing." Surg Oncol 1, no. 1 (February 1992): 87-95. Link to Item
  - Kemeny, N, Seiter, K, Niedzwiecki, D, Chapman, D, Sigurdson, E, Cohen, A, Botet, J, Oderman, P, and Murray, P. "A randomized trial of intrahepatic infusion of fluorodeoxyuridine with dexamethasone versus fluorodeoxyuridine alone in the treatment of metastatic colorectal cancer." Cancer 69, no. 2 (January 15, 1992): 327-334. Link to Item
  - Atiq, OT, Kemeny, N, Niedzwiecki, D, and Botet, J. "Treatment of unresectable primary liver cancer with intrahepatic fluorodeoxyuridine and mitomycin C through an implantable pump." Cancer 69, no. 4 (January 1, 1992): 920-924. Full Text
  - Kemeny, N, Seiter, K, Niedzwiecki, D, Chapman, D, Sigurdson, E, Cohen, A, Botet, J, Oderman, P, and Murray, P. "A randomized trial of intrahepatic infusion of fluorodeoxyuridine with dexamethasone versus fluorodeoxyuridine alone in the treatment of metastatic colorectal cancer." Cancer 69, no. 2 (January 1, 1992): 327-334. Full Text
  - Kemeny, N, Seiter, K, Martin, D, Urmacher, C, Niedzwiecki, D, Kurtz, RC, Costa, P, and Murray, M. "A new syndrome: ascites, hyperbilirubinemia, and hypoalbuminemia after biochemical modulation of fluorouracil with N-phosphonacetyl-L-aspartate (PALA)." Ann Intern Med 115, no. 12 (December 15, 1991): 946-951. Link to Item
  - Kelsen, D, Hudis, C, Niedzwiecki, D, Dougherty, J, Casper, E, Botet, J, Vinciguerra, V, and Rosenbluth, R. "A phase III comparison trial of streptozotocin, mitomycin, and 5-fluorouracil with cisplatin, cytosine arabinoside, and caffeine in patients with advanced pancreatic carcinoma." Cancer 68, no. 5 (September 1, 1991): 965-969. Link to Item
  - Romanini, A, Lin, JT, Niedzwiecki, D, Bunni, M, Priest, DG, and Bertino, JR. "Role of folylpolyglutamates in biochemical modulation of fluoropyrimidines by leucovorin." Cancer Res 51, no. 3 (February 1, 1991): 789-793. Link to Item
  - Kelsen, D, Hudis, C, Niedzwiecki, D, Dougherty, J, Casper, E, Botet, J, Vinciguerra, V, and Rosenbluth, R. "A phase III comparison trial of streptozotocin, mitomycin, and 5‐fluorouracil with cisplatin, cytosine arabinoside, and caffeine in patients with advanced pancreatic carcinoma." Cancer 68, no. 5 (January 1, 1991): 965-969. Full Text
  - Krown, SE, Niedzwiecki, D, Bhalla, RB, Flomenberg, N, Bundow, D, and Chapman, D. "Relationship and prognostic value of endogenous interferon-alpha, beta 2-microglobulin, and neopterin serum levels in patients with Kaposi sarcoma and AIDS." J Acquir Immune Defic Syndr 4, no. 9 (1991): 871-880. Link to Item
  - Lin, JT, Tong, WP, Trippett, TM, Niedzwiecki, D, Tao, Y, Tan, C, Steinherz, P, Schweitzer, BI, and Bertino, JR. "Basis for natural resistance to methotrexate in human acute non-lymphocytic leukemia." Leuk Res 15, no. 12 (1991): 1191-1196. Link to Item
  - Kelsen, DP, Minsky, B, Smith, M, Beitler, J, Niedzwiecki, D, Chapman, D, Bains, M, Burt, M, Heelan, R, and Hilaris, B. "Preoperative therapy for esophageal cancer: a randomized comparison of chemotherapy versus radiation therapy." J Clin Oncol 8, no. 8 (August 1990): 1352-1361. Full Text Link to Item
  - Niedzwiecki, D, and Simonoff, JS. "Estimation and inference in pharmacokinetic models: the effectiveness of model reformulation and resampling methods for functions of parameters." J Pharmacokinet Biopharm 18, no. 4 (August 1990): 361-377. Link to Item
  - Grant, IH, Gold, JW, Rosenblum, M, Niedzwiecki, D, and Armstrong, D. "Toxoplasma gondii serology in HIV-infected patients: the development of central nervous system toxoplasmosis in AIDS." AIDS 4, no. 6 (June 1990): 519-521. Link to Item
  - Krown, SE, Gold, JW, Niedzwiecki, D, Bundow, D, Flomenberg, N, Gansbacher, B, and Brew, BJ. "Interferon-alpha with zidovudine: safety, tolerance, and clinical and virologic effects in patients with Kaposi sarcoma associated with the acquired immunodeficiency syndrome (AIDS)." Ann Intern Med 112, no. 11 (June 1, 1990): 812-821. Link to Item
  - Bovbjerg, DH, Redd, WH, Maier, LA, Holland, JC, Lesko, LM, Niedzwiecki, D, Rubin, SC, and Hakes, TB. "Anticipatory immune suppression and nausea in women receiving cyclic chemotherapy for ovarian cancer." J Consult Clin Psychol 58, no. 2 (April 1990): 153-157. Link to Item
  - Kambhu, SA, Kelsen, DP, Fiore, J, Niedzwiecki, D, Chapman, D, Vinciguerra, V, and Rosenbluth, R. "Metastatic adenocarcinomas of unknown primary site. Prognostic variables and treatment results." Am J Clin Oncol 13, no. 1 (February 1990): 55-60. Link to Item
  - Kemeny, N, Israel, K, Niedzwiecki, D, Chapman, D, Botet, J, Minsky, B, Vinciguerra, V, Rosenbluth, R, Bosselli, B, and Cochran, C. "Randomized study of continuous infusion fluorouracil versus fluorouracil plus cisplatin in patients with metastatic colorectal cancer." J Clin Oncol 8, no. 2 (February 1990): 313-318. Full Text Link to Item
  - Motzer, RJ, Niedzwiecki, D, Isaacs, M, Menendez-Botet, C, Tong, WP, Flombaum, C, Scher, HI, and Bosl, GJ. "Carboplatin-based chemotherapy with pharmacokinetic analysis for patients with hemodialysis-dependent renal insufficiency." Cancer Chemother Pharmacol 27, no. 3 (1990): 234-238. Link to Item
  - Niedt, GW, Myskowski, PL, Urmacher, C, Niedzwiecki, D, Chapman, D, and Safai, B. "Histology of early lesions of AIDS-associated Kaposi's sarcoma." Mod Pathol 3, no. 1 (January 1990): 64-70. Link to Item
  - Rivoire, M, Yoshida, K, Divgi, C, Niedzwiecki, D, Chapman, D, and Sigurdson, E. "[Intraportal injection of specific monoclonal antibody in nude mice with liver metastasis]." Chirurgie 116, no. 8-9 (1990): 721-729. Link to Item
  - Schneider, A, Kemeny, N, Chapman, D, Niedzwiecki, D, and Oderman, P. "Intrahepatic mitomycin C as a salvage treatment for patients with hepatic metastases from colorectal carcinoma." Cancer 64, no. 11 (December 1, 1989): 2203-2206. Link to Item
  - Dougherty, JB, Kelsen, D, Kemeny, N, Magill, G, Botet, J, and Niedzwiecki, D. "Advanced pancreatic cancer: a phase I-II trial of cisplatin, high-dose cytarabine, and caffeine." J Natl Cancer Inst 81, no. 22 (November 15, 1989): 1735-1738. Link to Item
  - Nanus, DM, Kelsen, DP, Niedzwiecki, D, Chapman, D, Brennan, M, Cheng, E, and Melamed, M. "Flow cytometry as a predictive indicator in patients with operable gastric cancer." J Clin Oncol 7, no. 8 (August 1989): 1105-1112. Full Text Link to Item
  - Niedzwiecki, DM, Cubeddu, LX, and Mailman, RB. "Comparative antidopaminergic properties of thioridazine, mesoridazine and sulforidazine on the corpus striatum." The Journal of pharmacology and experimental therapeutics 250, no. 1 (July 1989): 117-125.
  - Kemeny, N, Niedzwiecki, D, Reichman, B, Botet, J, Vinciguerra, V, Michaelson, R, Rosenbluth, R, and Deonarine, S. "Cisplatin and 5-fluorouracil infusion for metastatic colorectal carcinoma. Differences in survival in two patient groups with similar response rates." Cancer 63, no. 6 (March 15, 1989): 1065-1069. Link to Item
  - Kemeny, N, Niedzwiecki, D, Shurgot, B, and Oderman, P. "Prognostic variables in patients with hepatic metastases from colorectal cancer. Importance of medical assessment of liver involvement." Cancer 63, no. 4 (February 15, 1989): 742-747. Link to Item
  - Kemeny, N, Niedzwiecki, D, Reichman, B, Botet, J, Vinciguerra, V, Michaelson, R, Rosenbluth, R, and Deonarine, S. "Cisplatin and 5‐fluorouracil infusion for metastatic colorectal carcinoma. Differences in survival in two patient groups with similar response rates." Cancer 63, no. 6 (January 1, 1989): 1065-1069. Full Text
  - Kemeny, N, Niedzwiecki, D, Shurgot, B, and Oderman, P. "Prognostic variables in patients with hepatic metastases from colorectal cancer. Importance of medical assessment of liver involvement." Cancer 63, no. 4 (January 1, 1989): 742-747. Full Text
  - Schneider, A, Kemeny, N, Chapman, D, Niedzwiecki, D, and Oderman, P. "Intrahepatic mitomycin C as a salvage treatment for patients with hepatic metastases from colorectal carcinoma." Cancer 64, no. 11 (January 1, 1989): 2203-2206. Full Text
  - Frame, J, Kelsen, D, Kemeny, N, Cheng, E, Niedzwiecki, D, Heelan, R, and Lippermann, R. "A phase II trial of streptozotocin and adriamycin in advanced APUD tumors." Am J Clin Oncol 11, no. 4 (August 1988): 490-495. Link to Item
  - Myskowski, PL, Niedzwiecki, D, Shurgot, BA, Kaufman, D, Krown, SE, Nisce, L, and Safai, B. "AIDS-associated Kaposi's sarcoma: variables associated with survival." J Am Acad Dermatol 18, no. 6 (June 1988): 1299-1306. Link to Item
  - Glazer, WM, Morgenstern, H, Niedzwiecki, D, and Hughes, J. "Heterogeneity of tardive dyskinesia. A multivariate analysis." Br J Psychiatry 152 (February 1988): 253-259. Link to Item
  - Glazer, WM, Morgenstern, H, Niedzwiecki, D, and Hughes, J. "Heterogeneity of tardive dyskinesia. A multivariate analysis." British Journal of Psychiatry 152, no. FEB. (January 1, 1988): 253-259.
  - Scher, HI, Shank, B, Chapman, R, Geller, N, Pinsky, C, Gralla, R, Kelsen, D, Bosl, G, Golbey, R, Petroni, G, Niedzwiecki, D, Martini, N, Heelan, R, Hollander, P, Hilaris, B, Oettgen, H, and Wittes, RE. "Randomized trial of combined modality therapy with and without thymosin fraction v in the treatment of small cell lung cancer." Cancer Research 48, no. 6 (1988): 1663-1670.
  - Allen-Mersh, TG, Kemeny, N, Niedzwiecki, D, Shurgot, B, and Daly, JM. "Significance of a fall in serum CEA concentration in patients treated with cytotoxic chemotherapy for disseminated colorectal cancer." Gut 28, no. 12 (December 1987): 1625-1629. Link to Item
  - Fanucchi, MP, Walsh, TD, Fleisher, M, Lokos, G, Williams, L, Cassidy, C, Vidal, P, Chou, TC, Niedzwiecki, D, and Young, CW. "Phase I and clinical pharmacology study of trimetrexate administered weekly for three weeks." Cancer Res 47, no. 12 (June 15, 1987): 3303-3308. Link to Item
  - Morgenstern, H, Glazer, WM, Niedzwiecki, D, and Nourjah, P. "The impact of neuroleptic medication on tardive dyskinesia: a meta-analysis of published studies." Am J Public Health 77, no. 6 (June 1987): 717-724. Link to Item
  - Sternberg, CN, Sordillo, PP, Cheng, E, Chuang, YJ, and Niedzwiecki, D. "Evaluation of new anticancer agents against human pancreatic carcinomas in nude mice." Am J Clin Oncol 10, no. 3 (June 1987): 219-221. Link to Item
  - Fanucchi, MP, Kinahan, JJ, Samuels, LL, Hancock, C, Chou, TC, Niedzwiecki, D, Farag, F, Vidal, PM, DeGraw, JI, and Sternberg, SS. "Toxicity, elimination, and metabolism of 10-ethyl-10-deazaaminopterin in rats and dogs." Cancer Res 47, no. 9 (May 1, 1987): 2334-2339. Link to Item
  - Krown, SE, Mintzer, D, Cunningham-Rundles, S, Niedzwiecki, D, Krim, M, Einzig, AI, Gabrilove, JL, Shurgot, B, and Gessula, J. "High-dose human lymphoblastoid interferon in metastatic colorectal cancer: clinical results and modification of biological responses." Cancer Treat Rep 71, no. 1 (January 1987): 39-45. Link to Item
  - Bajorin, DF, Bosl, GJ, Alcock, NW, Niedzwiecki, D, Gallina, E, and Shurgot, B. "Pharmacokinetics of cis-diamminedichloroplatinum(II) after administration in hypertonic saline." Cancer Res 46, no. 11 (November 1986): 5969-5972. Link to Item
  - Scher, HI, Sternberg, C, Heston, WD, Watson, RC, Niedzwiecki, D, Smart, T, Hollander, P, and Yagoda, A. "Etoposide in prostatic cancer: experimental studies and phase II trial in patients with bidimensionally measurable disease." Cancer Chemother Pharmacol 18, no. 1 (1986): 24-26. Link to Item
  - Hancock, C, Bacha, D, and Niedzwiecki, D. "Pharmacokinetics of intravenous (IV) and oral (PO) idarubicin (4DMDR) in children with cancer." Proceedings of the American Association for Cancer Research VOL. 26 (1985): No.-621.
  - Hancock, C, Niedzwiecki, D, and Merke, D. "Pharmacokinetics of idarubicin (4-DMDR) with or without cytarabine (ARA-C) in patients (pts) with relapsed leukemia." Proceedings of the American Association for Cancer Research VOL. 26 (1985): No.-622.

Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.

Education, Training, & Certifications

Duke Appointment History

Selected Grants

Selected Publications

Conference Papers

Journal Articles